☰

Lorenzo Galluzzi - Publications

Affiliations: 
Paris11 
Tree Info Similar researchers PubMed Report error

449 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Li XQ, Yamazaki T, He T, Alam MM, Liu J, Trivett AL, Sveinbjørnsson B, Rekdal Ø, Galluzzi L, Oppenheim JJ, Yang D. LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells. Frontiers in Immunology. 15: 1332922. PMID 38545099 DOI: 10.3389/fimmu.2024.1332922  0.334
2024 Chen X, Tsvetkov AS, Shen HM, Isidoro C, Ktistakis NT, Linkermann A, Koopman WJH, Simon HU, Galluzzi L, Luo S, Xu D, Gu W, Peulen O, Cai Q, Rubinsztein DC, et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy. PMID 38442890 DOI: 10.1080/15548627.2024.2319901  0.442
2024 Dai E, Chen X, Linkermann A, Jiang X, Kang R, Kagan VE, Bayir H, Yang WS, Garcia-Saez AJ, Ioannou MS, Janowitz T, Ran Q, Gu W, Gan B, Krysko DV, ... ... Galluzzi L, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nature Cell Biology. PMID 38424270 DOI: 10.1038/s41556-024-01360-8  0.365
2023 Kroemer G, Chan TA, Eggermont AMM, Galluzzi L. Immunosurveillance in clinical cancer management. Ca: a Cancer Journal For Clinicians. PMID 37880100 DOI: 10.3322/caac.21818  0.463
2023 Kepp O, Liu P, Kroemer G, Galluzzi L. A mitochondrial checkpoint to adaptive anticancer immunity. Oncoimmunology. 12: 2271693. PMID 37860277 DOI: 10.1080/2162402X.2023.2271693  0.438
2023 Galassi C, Klapp V, Yamazaki T, Galluzzi L. Molecular determinants of immunogenic cell death elicited by radiation therapy. Immunological Reviews. PMID 37679959 DOI: 10.1111/imr.13271  0.351
2023 Zhao L, Liu P, Mao M, Zhang S, Bigenwald C, Dutertre CA, Lehmann CHK, Pan H, Paulhan N, Amon L, Buque A, Yamazaki T, Galluzzi L, Kloeckner B, Silvin A, et al. BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance. Cancer Discovery. PMID 37623817 DOI: 10.1158/2159-8290.CD-22-1338  0.419
2023 Cultrara C, Uhl C, Kirby K, Abed Elrazaq E, Zellander A, Andrews DW, Scott CB, Galluzzi L, Exley MA, Zilberberg J. A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma. Journal For Immunotherapy of Cancer. 11. PMID 37550054 DOI: 10.1136/jitc-2023-006880  0.302
2023 Galluzzi L, Myint M. Cell death and senescence. Journal of Translational Medicine. 21: 425. PMID 37386590 DOI: 10.1186/s12967-023-04297-y  0.305
2023 Dhaouadi N, Vitto VAM, Pinton P, Galluzzi L, Marchi S. Ca signaling and cell death. Cell Calcium. 113: 102759. PMID 37210868 DOI: 10.1016/j.ceca.2023.102759  0.334
2023 Guilbaud E, Kroemer G, Galluzzi L. Calreticulin exposure orchestrates innate immunosurveillance. Cancer Cell. 41: 1014-1016. PMID 37207656 DOI: 10.1016/j.ccell.2023.04.015  0.352
2023 Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Aqeilan RI, Arama E, Baehrecke EH, ... ... Galluzzi L, et al. Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death and Differentiation. PMID 37100955 DOI: 10.1038/s41418-023-01153-w  0.703
2023 Klapp V, Álvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L. The DNA Damage Response and Inflammation in Cancer. Cancer Discovery. OF1-OF25. PMID 37026695 DOI: 10.1158/2159-8290.CD-22-1220  0.437
2023 Galluzzi L, Kepp O, Hett E, Kroemer G, Marincola FM. Immunogenic cell death in cancer: concept and therapeutic implications. Journal of Translational Medicine. 21: 162. PMID 36864446 DOI: 10.1186/s12967-023-04017-6  0.518
2023 López-Otín C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metabolism. 35: 12-35. PMID 36599298 DOI: 10.1016/j.cmet.2022.11.001  0.635
2022 Tong L, Jiménez-Cortegana C, Tay AHM, Wickström S, Galluzzi L, Lundqvist A. NK cells and solid tumors: therapeutic potential and persisting obstacles. Molecular Cancer. 21: 206. PMID 36319998 DOI: 10.1186/s12943-022-01672-z  0.346
2022 Galluzzi L, Kroemer G. Calreticulin surface presentation can promote quality control of hematopoietic stem cells. Trends in Immunology. PMID 36307308 DOI: 10.1016/j.it.2022.10.008  0.379
2022 Álvarez-Abril B, Bloy N, Galassi C, Sato A, Jiménez-Cortegana C, Klapp V, Aretz A, Guilbaud E, Buqué A, Galluzzi L, Yamazaki T. Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Methods in Cell Biology. 172: 17-36. PMID 36064223 DOI: 10.1016/bs.mcb.2022.05.002  0.322
2022 Galassi C, Ruan Y, Sato A, Jiménez-Cortegana C, Klapp V, Bloy N, Guilbaud E, Petroni G, Buqué A, Galluzzi L, Yamazaki T. RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. Methods in Cell Biology. 172: 145-161. PMID 36064221 DOI: 10.1016/bs.mcb.2022.05.005  0.321
2022 Jiménez-Cortegana C, Klapp V, Bloy N, Galassi C, Sato A, Yamazaki T, Buqué A, Galluzzi L, Petroni G. Cytofluorometric assessment of cell cycle progression in irradiated cells. Methods in Cell Biology. 172: 1-16. PMID 36064218 DOI: 10.1016/bs.mcb.2021.12.025  0.354
2022 Galluzzi L, Kroemer G. Immuno-epigenetic escape of cancer stem cells. Nature Immunology. 23: 1300-1302. PMID 36002649 DOI: 10.1038/s41590-022-01293-0  0.367
2022 Le Naour J, Sztupinszki Z, Carbonnier V, Casiraghi O, Marty V, Galluzzi L, Szallasi Z, Kroemer G, Vacchelli E. A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients. Oncoimmunology. 11: 2059878. PMID 35481288 DOI: 10.1080/2162402X.2022.2059878  0.679
2022 Jiménez-Cortegana C, Galassi C, Klapp V, Gabrilovich DI, Galluzzi L. Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer Immunology Research. 10: 545-557. PMID 35426936 DOI: 10.1158/2326-6066.CIR-21-1105  0.32
2022 Fucikova J, Palova-Jelinkova L, Klapp V, Holicek P, Lanickova T, Kasikova L, Drozenova J, Cibula D, Álvarez-Abril B, García-Martínez E, Spisek R, Galluzzi L. Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. Trends in Cancer. PMID 35181272 DOI: 10.1016/j.trecan.2022.01.010  0.335
2022 Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nature Immunology. PMID 35145297 DOI: 10.1038/s41590-022-01132-2  0.49
2021 Petroni G, Cantley LC, Santambrogio L, Formenti SC, Galluzzi L. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nature Reviews. Clinical Oncology. PMID 34819622 DOI: 10.1038/s41571-021-00579-w  0.325
2021 Humeau J, Le Naour J, Galluzzi L, Kroemer G, Pol JG. Trial watch: intratumoral immunotherapy. Oncoimmunology. 10: 1984677. PMID 34676147 DOI: 10.1080/2162402X.2021.1984677  0.479
2021 Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cadwell K, Cecconi F, Choi AMK, Choi ME, Chu CT, Codogno P, Colombo MI, Cuervo AM, ... ... Galluzzi L, et al. Autophagy in major human diseases. The Embo Journal. e108863. PMID 34459017 DOI: 10.15252/embj.2021108863  0.651
2021 Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, Galluzzi L. ATP and cancer immunosurveillance. The Embo Journal. e108130. PMID 34121201 DOI: 10.15252/embj.2021108130  0.399
2021 Galluzzi L, Garg AD. Immunology of Cell Death in Cancer Immunotherapy. Cells. 10. PMID 34063358 DOI: 10.3390/cells10051208  0.352
2021 Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Galluzzi L, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280  0.804
2021 Buqué A, Galluzzi L, Kroemer G. Ketosis versus carbotoxicity - metabolism determines the outcome of cancer immunotherapy. Molecular & Cellular Oncology. 8: 1868266. PMID 33553614 DOI: 10.1080/23723556.2020.1868266  0.314
2021 Petroni G, Kroemer G, Galluzzi L. Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy. Trends in Cancer. PMID 33518493 DOI: 10.1016/j.trecan.2021.01.005  0.382
2020 Petroni G, Buqué A, Zitvogel L, Kroemer G, Galluzzi L. Immunomodulation by targeted anticancer agents. Cancer Cell. PMID 33338426 DOI: 10.1016/j.ccell.2020.11.009  0.345
2020 Yamazaki T, Pedro JMB, Galluzzi L, Kroemer G, Pietrocola F. Autophagy in the cancer-immunity dialogue. Advanced Drug Delivery Reviews. PMID 33301821 DOI: 10.1016/j.addr.2020.12.003  0.727
2020 Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death & Disease. 11: 1013. PMID 33243969 DOI: 10.1038/s41419-020-03221-2  0.524
2020 Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, ... ... Galluzzi L, et al. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature Communications. 11: 4787. PMID 32943636 DOI: 10.1038/S41467-020-18719-8  0.37
2020 Frega G, Wu Q, Le Naour J, Vacchelli E, Galluzzi L, Kroemer G, Kepp O. Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. Oncoimmunology. 9: 1796002. PMID 32934889 DOI: 10.1080/2162402X.2020.1796002  0.688
2020 Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 9: 1777625. PMID 32934882 DOI: 10.1080/2162402X.2020.1777625  0.701
2020 Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G. Trial watch: STING agonists in cancer therapy. Oncoimmunology. 9: 1777624. PMID 32934881 DOI: 10.1080/2162402X.2020.1777624  0.697
2020 Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: TLR3 agonists in cancer therapy. Oncoimmunology. 9: 1771143. PMID 32934877 DOI: 10.1080/2162402X.2020.1771143  0.689
2020 Buque A, Bloy N, Petroni G, Kroemer G, Galluzzi L. NK cells beat T cells at early breast cancer control. Oncoimmunology. 9: 1806010. PMID 32923169 DOI: 10.1080/2162402X.2020.1806010  0.477
2020 Petroni G, Vitale I, Galluzzi L. Caspase 2 and p53 Reunited in Tumor Control. Trends in Cell Biology. PMID 32921524 DOI: 10.1016/J.Tcb.2020.09.001  0.443
2020 Hensler M, Kasikova L, Fiser K, Rakova J, Skapa P, Laco J, Lanickova T, Pecen L, Truxova I, Vosahlikova S, Moserova I, Praznovec I, Drochytek V, Rehackova M, Brtnicky T, ... ... Galluzzi L, et al. M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer. Journal For Immunotherapy of Cancer. 8. PMID 32819974 DOI: 10.1136/Jitc-2020-000979  0.309
2020 Galluzzi L, Humeau J, Buqué A, Zitvogel L, Kroemer G. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews. Clinical Oncology. PMID 32760014 DOI: 10.1038/S41571-020-0413-Z  0.534
2020 Yamazaki T, Kirchmair A, Sato A, Buqué A, Rybstein M, Petroni G, Bloy N, Finotello F, Stafford L, Navarro Manzano E, Ayala de la Peña F, García-Martínez E, Formenti SC, Trajanoski Z, Galluzzi L. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature Immunology. PMID 32747819 DOI: 10.1038/S41590-020-0751-0  0.431
2020 Fucikova J, Spisek R, Kroemer G, Galluzzi L. Calreticulin and cancer. Cell Research. PMID 32733014 DOI: 10.1038/S41422-020-0383-9  0.547
2020 Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, ... ... Galluzzi L, et al. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature Communications. 11: 3819. PMID 32732875 DOI: 10.1038/S41467-020-17644-0  0.471
2020 Buqué A, Bloy N, Kroemer G, Galluzzi L. Potential mechanisms of cancer prevention by nicotinamide. British Journal of Pharmacology. PMID 32383227 DOI: 10.1111/Bph.15096  0.439
2020 Petroni G, Galluzzi L. Cancer Immunotherapy with CDK7 Inhibitors. Trends in Cancer. 6: 361-363. PMID 32348731 DOI: 10.1016/J.Trecan.2020.02.005  0.429
2020 Petroni G, Formenti SC, Chen-Kiang S, Galluzzi L. Immunomodulation by anticancer cell cycle inhibitors. Nature Reviews. Immunology. PMID 32346095 DOI: 10.1038/S41577-020-0300-Y  0.469
2020 Chong SJF, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S. Noncanonical Cell Fate Regulation by Bcl-2 Proteins. Trends in Cell Biology. PMID 32307222 DOI: 10.1016/J.Tcb.2020.03.004  0.524
2020 Galluzzi L, Kroemer G. Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors? Trends in Cell Biology. 30: 339-340. PMID 32302546 DOI: 10.1016/J.Tcb.2020.02.004  0.5
2020 Galluzzi L, Petroni G, Kroemer G. Immunogenicity of cell death driven by immune effectors. Journal For Immunotherapy of Cancer. 8. PMID 32253221 DOI: 10.1136/Jitc-2020-000802  0.521
2020 Yamazaki T, Vanpouille-Box C, Demaria S, Galluzzi L. Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment. Cancer Treatment and Research. 180: 281-296. PMID 32215874 DOI: 10.1007/978-3-030-38862-1_10  0.482
2020 Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal For Immunotherapy of Cancer. 8. PMID 32209603 DOI: 10.1136/Jitc-2019-000337  0.78
2020 Rodriguez-Ruiz ME, Yamazaki T, Buqué A, Bloy N, Silva VAO, Stafford L, Sato A, Galluzzi L. Monitoring abscopal responses to radiation in mice. Methods in Enzymology. 635: 111-125. PMID 32122540 DOI: 10.1016/Bs.Mie.2019.04.014  0.368
2020 Yamazaki T, Buqué A, Ames TD, Galluzzi L. PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. Oncoimmunology. 9: 1721810. PMID 32117585 DOI: 10.1080/2162402X.2020.1721810  0.443
2020 Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. Oncoimmunology. 9: 1703449. PMID 32002302 DOI: 10.1080/2162402X.2019.1703449  0.567
2020 Fucikova J, Kline JP, Galluzzi L, Spisek R. Calreticulin arms NK cells against leukemia. Oncoimmunology. 9: 1671763. PMID 32002282 DOI: 10.1080/2162402X.2019.1671763  0.438
2020 Hazari Y, Bravo-San Pedro JM, Hetz C, Galluzzi L, Kroemer G. Autophagy in hepatic adaptation to stress. Journal of Hepatology. 72: 183-196. PMID 31849347 DOI: 10.1016/J.Jhep.2019.08.026  0.459
2020 Yamazaki T, Buqué A, Rybstein M, Chen J, Sato A, Galluzzi L. Correction to: Methods to Detect Immunogenic Cell Death In Vivo. Methods in Molecular Biology (Clifton, N.J.). 2055: C1. PMID 31701467 DOI: 10.1007/978-1-4939-9773-2_32  0.349
2020 Yamazaki T, Martinez AB, Rybstein M, Chen J, Sato A, Galluzzi L. Methods to Detect Immunogenic Cell Death In Vivo. Methods in Molecular Biology (Clifton, N.J.). 2055: 433-452. PMID 31502164 DOI: 10.1007/978-1-4939-9773-2_20  0.503
2020 Truxova I, Kasikova L, Salek C, Hensler M, Lysak D, Holicek P, Bilkova P, Holubova M, Chen X, Mikyskova R, Reinis M, Kovar M, Tomalova B, Kline J, Galluzzi L, et al. Abstract B96: Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-B96  0.438
2019 Rodriguez-Ruiz ME, Vitale I, Harrington KJ, Melero I, Galluzzi L. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nature Immunology. PMID 31873291 DOI: 10.1038/S41590-019-0561-4  0.465
2019 Galluzzi L. Targeting Mutant KRAS for Immunogenic Cell Death Induction. Trends in Pharmacological Sciences. PMID 31818506 DOI: 10.1016/j.tips.2019.11.004  0.337
2019 Lhuillier C, Galluzzi L. Preface-Dendritic cells: Master regulators of innate and adaptive immunity. International Review of Cell and Molecular Biology. 348: ix-xiv. PMID 31810557 DOI: 10.1016/S1937-6448(19)30095-4  0.358
2019 Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Galluzzi L, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. 30: 1171. PMID 31801056 DOI: 10.1016/j.cmet.2019.10.011  0.532
2019 Kasikova L, Hensler M, Truxova I, Skapa P, Laco J, Belicova L, Praznovec I, Vosahlikova S, Halaska MJ, Brtnicky T, Rob L, Presl J, Kostun J, Cremer I, Ryska A, ... ... Galluzzi L, et al. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal For Immunotherapy of Cancer. 7: 312. PMID 31747968 DOI: 10.1186/S40425-019-0781-Z  0.5
2019 Rodriguez-Ruiz ME, Buqué A, Hensler M, Chen J, Bloy N, Petroni G, Sato A, Yamazaki T, Fucikova J, Galluzzi L. Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology. 8: e1655964. PMID 31646105 DOI: 10.1080/2162402X.2019.1655964  0.445
2019 Buqué A, Rodriguez-Ruiz ME, Fucikova J, Galluzzi L. Apoptotic caspases cut down the immunogenicity of radiation. Oncoimmunology. 8: e1655364. PMID 31646103 DOI: 10.1080/2162402X.2019.1655364  0.352
2019 Sprooten J, Ceusters J, Coosemans A, Agostinis P, De Vleeschouwer S, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: dendritic cell vaccination for cancer immunotherapy. Oncoimmunology. 8: e1638212. PMID 31646087 DOI: 10.1080/2162402X.2019.1638212  0.42
2019 Truxova I, Kasikova L, Salek C, Hensler M, Lysak D, Holicek P, Bilkova P, Holubova M, Chen X, Mikyskova R, Reinis M, Kovar M, Tomalova B, Kline JP, Galluzzi L, et al. Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients. Haematologica. PMID 31582537 DOI: 10.3324/Haematol.2019.223933  0.426
2019 Buque A, Galluzzi L, Casares N. Today's special on the anticancer menu: immunomodulation by antifolates. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31562205 DOI: 10.1158/1078-0432.Ccr-19-2775  0.384
2019 Montrose DC, Galluzzi L. Drugging cancer metabolism: Expectations vs. reality. International Review of Cell and Molecular Biology. 347: 1-26. PMID 31451211 DOI: 10.1016/Bs.Ircmb.2019.07.007  0.372
2019 Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Galluzzi L, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. PMID 31422903 DOI: 10.1016/J.Cmet.2019.07.010  0.636
2019 Ko EC, Galluzzi L. Radiation unlocks the therapeutic potential of immune checkpoint blockers in lung cancer patients. Oncoimmunology. 8: 1606624. PMID 31413913 DOI: 10.1080/2162402X.2019.1606624  0.344
2019 Tatsuno K, Yamazaki T, Hanlon D, Han P, Robinson E, Sobolev O, Yurter A, Rivera-Molina F, Arshad N, Edelson RL, Galluzzi L. Extracorporeal photochemotherapy induces bona fide immunogenic cell death. Cell Death & Disease. 10: 578. PMID 31371700 DOI: 10.1038/S41419-019-1819-3  0.475
2019 Deutsch E, Chargari C, Galluzzi L, Kroemer G. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. The Lancet. Oncology. 20: e452-e463. PMID 31364597 DOI: 10.1016/S1470-2045(19)30171-8  0.425
2019 Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metabolism. 30: 36-50. PMID 31269428 DOI: 10.1016/J.Cmet.2019.06.001  0.473
2019 Galluzzi L, Green DR. Autophagy-Independent Functions of the Autophagy Machinery. Cell. 177: 1682-1699. PMID 31199916 DOI: 10.1016/J.Cell.2019.05.026  0.356
2019 Lévesque S, Pol JG, Ferrere G, Galluzzi L, Zitvogel L, Kroemer G. Trial watch: dietary interventions for cancer therapy. Oncoimmunology. 8: 1591878. PMID 31143510 DOI: 10.1080/2162402X.2019.1591878  0.452
2019 Bedognetti D, Ceccarelli M, Galluzzi L, Lu R, Palucka K, Samayoa J, Spranger S, Warren S, Wong KK, Ziv E, Chowell D, Coussens LM, De Carvalho DD, DeNardo DG, Galon J, et al. Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Journal For Immunotherapy of Cancer. 7: 131. PMID 31113486 DOI: 10.1186/S40425-019-0602-4  0.416
2019 Fucikova J, Rakova J, Hensler M, Kasikova L, Belicová L, Hladikova K, Truxova I, Skapa P, Laco J, Pecen L, Praznovec I, Halaska MJ, Brtnicky T, Kodet R, Fialová A, ... ... Galluzzi L, et al. TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31076549 DOI: 10.1158/1078-0432.Ccr-18-4175  0.348
2019 Stoll G, Kremer M, Bloy N, Joseph A, Castedo M, Meurice G, Klein C, Galluzzi L, Michels J, Kroemer G. Metabolic enzymes expressed by cancer cells impact the immune infiltrate. Oncoimmunology. 8: e1571389. PMID 31069148 DOI: 10.1080/2162402X.2019.1571389  0.74
2019 Vitale I, Manic G, Galassi C, Galluzzi L. Stress responses in stromal cells and tumor homeostasis. Pharmacology & Therapeutics. PMID 30998941 DOI: 10.1016/J.Pharmthera.2019.04.004  0.44
2019 Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, Durand S, Bossut N, Chery A, Souquere S, Pierron G, Vartholomaiou E, Zamzami N, Soussi T, Sauvat A, ... ... Galluzzi L, et al. Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate. Cell Reports. 27: 820-834.e9. PMID 30995479 DOI: 10.1016/J.Celrep.2019.03.058  0.796
2019 Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. PMID 30962044 DOI: 10.1016/J.Tcb.2019.03.005  0.476
2019 Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. 29: 449-451. PMID 30962043 DOI: 10.1016/j.tcb.2019.03.002  0.392
2019 Wennerberg E, Galluzzi L. Born to Kill: NK Cells Go to War against Cancer. Trends in Cancer. 5: 143-145. PMID 30898260 DOI: 10.1016/J.Trecan.2018.12.005  0.446
2019 Galluzzi L, Kroemer G. Etiological involvement of CFTR in apparently unrelated human diseases. Molecular & Cellular Oncology. 6: 1558874. PMID 30788425 DOI: 10.1080/23723556.2018.1558874  0.349
2019 Vitale I, Sistigu A, Manic G, Rudqvist NP, Trajanoski Z, Galluzzi L. Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. Trends in Cell Biology. PMID 30765144 DOI: 10.1016/J.Tcb.2019.01.003  0.374
2019 Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, Yirong W, Dy GK, Yau E, Early A, Chen H, ... ... Galluzzi L, et al. Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. Journal For Immunotherapy of Cancer. 7: 27. PMID 30709424 DOI: 10.1186/S40425-019-0506-3  0.342
2019 Rudqvist NP, Galluzzi L. T Cells: Friends and Foes. International Review of Cell and Molecular Biology. 342: xi-xiv. PMID 30635096 DOI: 10.1016/S1937-6448(19)30009-7  0.306
2019 Kroemer G, Zitvogel L, Galluzzi L. Victories and deceptions in tumor immunology: Stimuvax Oncoimmunology. 2: e23687. PMID 23483762 DOI: 10.4161/Onci.23687  0.52
2019 Liberto MD, Hu Y, Huang X, Lee CY, Wang K, Bartlett NL, Ridling L, Blum KA, Maddocks KJ, Park SI, Ruan J, Eng K, Galluzzi L, Leonard JP, Martin P, et al. Composite Copy Number Variation in CDK4 , CDKN2A and RB1 Predisposes Mantle Cell Lymphoma to Expansion of PD1+ Tumor Cells and Resistance to CDK4/6 Inhibitor Therapy as Revealed by Integrative Longitudinal scRNA-seq Blood. 134: 1492-1492. DOI: 10.1182/Blood-2019-130944  0.356
2019 Lee CY, Liberto MD, Hu Y, Huang X, Bartlett NL, Maddocks KJ, Leonard JP, Rudqvist N, Galluzzi L, Martin P, Elemento O, Chen-Kiang S. T-Cell Clonal Expansion and Activation Associated with Durable Clinical Response to Dual BTK and CDK4/6 Inhibitor Therapy in Mantle Cell Lymphoma Blood. 134: 3973-3973. DOI: 10.1182/Blood-2019-122322  0.398
2019 Yamazaki T, Ames TD, Galluzzi L. Abstract B199: Potent induction of immunogenic cell death by PT-112 Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B199  0.443
2019 Rybstein M, Yamazaki T, Martinez AB, Galluzzi L. Abstract A150: Enhancing abscopal responses to radiation therapy by manipulating autophagy Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A150  0.491
2018 Truxova I, Kasikova L, Hensler M, Skapa P, Laco J, Pecen L, Belicova L, Praznovec I, Halaska MJ, Brtnicky T, Salkova E, Rob L, Kodet R, Goc J, Sautes-Fridman C, ... ... Galluzzi L, et al. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. Journal For Immunotherapy of Cancer. 6: 139. PMID 30526667 DOI: 10.1186/S40425-018-0446-3  0.395
2018 Galluzzi L, Kroemer G. Potent immunosuppressive effects of the oncometabolite -2-hydroxyglutarate. Oncoimmunology. 7: e1528815. PMID 30524910 DOI: 10.1080/2162402X.2018.1528815  0.548
2018 Smith M, García-Martínez E, Pitter MR, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in cancer immunotherapy. Oncoimmunology. 7: e1526250. PMID 30524908 DOI: 10.1080/2162402X.2018.1526250  0.439
2018 Bezu L, Kepp O, Cerrato G, Pol J, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Peptide-based vaccines in anticancer therapy. Oncoimmunology. 7: e1511506. PMID 30524907 DOI: 10.1080/2162402X.2018.1511506  0.436
2018 G Pol J, Lévesque S, Workenhe ST, Gujar S, Le Boeuf F, R Clements D, Fahrner JE, Fend L, C Bell J, L Mossman K, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. Oncoimmunology. 7: e1503032. PMID 30524901 DOI: 10.1080/2162402X.2018.1503032  0.479
2018 Marchi S, Corricelli M, Branchini A, Vitto VAM, Missiroli S, Morciano G, Perrone M, Ferrarese M, Giorgi C, Pinotti M, Galluzzi L, Kroemer G, Pinton P. Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca levels and tumor growth. The Embo Journal. PMID 30504268 DOI: 10.15252/Embj.201899435  0.444
2018 Galluzzi L, Yamazaki T, Kroemer G. Linking cellular stress responses to systemic homeostasis. Nature Reviews. Molecular Cell Biology. PMID 30305710 DOI: 10.1038/S41580-018-0068-0  0.496
2018 Galluzzi L, Chan TA, Kroemer G, Wolchok JD, López-Soto A. The hallmarks of successful anticancer immunotherapy. Science Translational Medicine. 10. PMID 30232229 DOI: 10.1126/Scitranslmed.Aat7807  0.497
2018 Galluzzi L, Spranger S, Fuchs E, López-Soto A. WNT Signaling in Cancer Immunosurveillance. Trends in Cell Biology. PMID 30220580 DOI: 10.1016/J.Tcb.2018.08.005  0.354
2018 Vanpouille-Box C, Demaria S, Formenti SC, Galluzzi L. Cytosolic DNA Sensing in Organismal Tumor Control. Cancer Cell. 34: 361-378. PMID 30216189 DOI: 10.1016/J.Ccell.2018.05.013  0.373
2018 Bonora M, Wieckowski MR, Sinclair DA, Kroemer G, Pinton P, Galluzzi L. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nature Reviews. Cardiology. PMID 30177752 DOI: 10.1038/S41569-018-0074-0  0.421
2018 Buqué A, Galluzzi L. Modeling Tumor Immunology and Immunotherapy in Mice. Trends in Cancer. 4: 599-601. PMID 30149876 DOI: 10.1016/J.Trecan.2018.07.003  0.398
2018 García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Cánovas MS, Conesa MAV, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology. 7: e1433982. PMID 29872569 DOI: 10.1080/2162402X.2018.1433982  0.462
2018 Galluzzi L, Vanpouille-Box C, Bakhoum SF, Demaria S. SnapShot: CGAS-STING Signaling. Cell. 173: 276-276.e1. PMID 29570996 DOI: 10.1016/J.Cell.2018.03.015  0.311
2018 Galluzzi L, Vanpouille-Box C. BAX and BAK at the Gates of Innate Immunity. Trends in Cell Biology. PMID 29555208 DOI: 10.1016/J.Tcb.2018.02.010  0.404
2018 Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L. The autophagic network and cancer. Nature Cell Biology. 20: 243-251. PMID 29476153 DOI: 10.1038/S41556-018-0042-2  0.469
2018 Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death and Differentiation. PMID 29362479 DOI: 10.1038/S41418-017-0012-4  0.541
2018 Carmona-Gutierrez D, Bauer MA, Zimmermann A, Aguilera A, Austriaco N, Ayscough K, Balzan R, Bar-Nun S, Barrientos A, Belenky P, Blondel M, Braun RJ, Breitenbach M, Burhans WC, Büttner S, ... ... Galluzzi L, et al. Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell (Graz, Austria). 5: 4-31. PMID 29354647 DOI: 10.15698/Mic2018.01.607  0.514
2017 Kroemer G, Galluzzi L. Lysosome-targeting agents in cancer therapy. Oncotarget. 8: 112168-112169. PMID 29348815 DOI: 10.18632/Oncotarget.21451  0.47
2017 Lhuillier C, Vanpouille-Box C, Galluzzi L, Formenti SC, Demaria S. Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers. Seminars in Cancer Biology. PMID 29258856 DOI: 10.1016/J.Semcancer.2017.12.007  0.346
2017 Chen JJ, Galluzzi L. Fighting Resilient Cancers with Iron. Trends in Cell Biology. PMID 29223642 DOI: 10.1016/J.Tcb.2017.11.007  0.366
2017 Porporato PE, Filigheddu N, Bravo-San Pedro JM, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Research. PMID 29219147 DOI: 10.1038/Cr.2017.155  0.542
2017 Pierini S, Perales-Linares R, Uribe-Herranz M, Pol JG, Zitvogel L, Kroemer G, Facciabene A, Galluzzi L. Trial watch: DNA-based vaccines for oncological indications. Oncoimmunology. 6: e1398878. PMID 29209575 DOI: 10.1080/2162402X.2017.1398878  0.407
2017 Garg AD, More S, Rufo N, Mece O, Sassano ML, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology. 6: e1386829. PMID 29209573 DOI: 10.1080/2162402X.2017.1386829  0.578
2017 Cabo M, Offringa R, Zitvogel L, Kroemer G, Muntasell A, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. Oncoimmunology. 6: e1371896. PMID 29209572 DOI: 10.1080/2162402X.2017.1371896  0.424
2017 Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, Fucikova J, Spisek R, Demaria S, Formenti SC, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 6: e1373237. PMID 29147629 DOI: 10.1080/2162402X.2017.1373237  0.5
2017 Fournier C, Martin F, Zitvogel L, Kroemer G, Galluzzi L, Apetoh L. Trial Watch: Adoptively transferred cells for anticancer immunotherapy. Oncoimmunology. 6: e1363139. PMID 29147628 DOI: 10.1080/2162402X.2017.1363139  0.53
2017 Vanpouille-Box C, Galluzzi L. CD103(+) cells at the forefront of anticancer immunity. Oncoimmunology. 6: e1356154. PMID 29147613 DOI: 10.1080/2162402X.2017.1356154  0.321
2017 Conroy JM, Pabla S, Glenn ST, Burgher B, Nesline M, Papanicolau-Sengos A, Andreas J, Giamo V, Lenzo FL, Hyland FCL, Omilian A, Bshara W, Qin M, He J, Puzanov I, ... ... Galluzzi L, et al. Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors. The Journal of Molecular Diagnostics : Jmd. PMID 29061374 DOI: 10.1016/J.Jmoldx.2017.10.001  0.316
2017 Wennerberg E, Vanpouille-Box C, Bornstein S, Yamazaki T, Demaria S, Galluzzi L. Immune recognition of irradiated cancer cells. Immunological Reviews. 280: 220-230. PMID 29027232 DOI: 10.1111/Imr.12568  0.477
2017 Bantug GR, Galluzzi L, Kroemer G, Hess C. The spectrum of T cell metabolism in health and disease. Nature Reviews. Immunology. PMID 28944771 DOI: 10.1038/Nri.2017.99  0.451
2017 Garg AD, Vara Perez M, Schaaf M, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer immunotherapy. Oncoimmunology. 6: e1328341. PMID 28811970 DOI: 10.1080/2162402X.2017.1328341  0.469
2017 López-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. Control of Metastasis by NK Cells. Cancer Cell. 32: 135-154. PMID 28810142 DOI: 10.1016/J.Ccell.2017.06.009  0.44
2017 Galluzzi L, Kroemer G. Secondary Necrosis: Accidental No More. Trends in Cancer. 3: 1-2. PMID 28718422 DOI: 10.1016/J.Trecan.2016.12.001  0.513
2017 Galluzzi L, Kroemer G. Novel immune checkpoint blocker to treat Merkel cell carcinoma. Oncoimmunology. 6: e1315496. PMID 28680746 DOI: 10.1080/2162402X.2017.1315496  0.47
2017 Galluzzi L, Kroemer G. An epigenetic modifier triggers therapeutic immune responses against breast cancer. Oncoimmunology. 6: e1313376. PMID 28638742 DOI: 10.1080/2162402X.2017.1313376  0.436
2017 Yamazaki T, Galluzzi L. TREX1 Cuts Down on Cancer Immunogenicity. Trends in Cell Biology. PMID 28625463 DOI: 10.1016/J.Tcb.2017.06.001  0.358
2017 Galluzzi L, Yamazaki T, Demaria S. Heavy Metal to Rock the Immune Infiltrate. Trends in Immunology. PMID 28602618 DOI: 10.1016/J.It.2017.05.007  0.361
2017 Pietrocola F, Bravo-San Pedro JM, Galluzzi L, Kroemer G. Autophagy in natural and therapy-driven anticancer immunosurveillance. Autophagy. 0. PMID 28598229 DOI: 10.1080/15548627.2017.1310356  0.757
2017 Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen EL, et al. Molecular definitions of autophagy and related processes. The Embo Journal. PMID 28596378 DOI: 10.15252/Embj.201796697  0.443
2017 Bonora M, Morganti C, Morciano G, Pedriali G, Lebiedzinska-Arciszewska M, Aquila G, Giorgi C, Rizzo P, Campo G, Ferrari R, Kroemer G, Wieckowski MR, Galluzzi L, Pinton P. Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation. Embo Reports. PMID 28566520 DOI: 10.15252/Embr.201643602  0.393
2017 Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and Mitophagy in Cardiovascular Disease. Circulation Research. 120: 1812-1824. PMID 28546358 DOI: 10.1161/Circresaha.117.311082  0.463
2017 Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nature Reviews. Drug Discovery. PMID 28529316 DOI: 10.1038/Nrd.2017.22  0.472
2017 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: Immunosuppressive cell death in cancer. Nature Reviews. Immunology. PMID 28480896 DOI: 10.1038/Nri.2017.48  0.525
2017 Vitale I, Manic G, De Maria R, Kroemer G, Galluzzi L. DNA Damage in Stem Cells. Molecular Cell. 66: 306-319. PMID 28475867 DOI: 10.1016/J.Molcel.2017.04.006  0.482
2017 Galluzzi L, Kroemer G. Calreticulin and type I interferon: An unsuspected connection. Oncoimmunology. 6: e1288334. PMID 28405522 DOI: 10.1080/2162402X.2017.1288334  0.334
2017 Galluzzi L, Bravo-San Pedro JM, Kroemer G. [Autophagy, fitness and longevity]. Medecine Sciences : M/S. 33: 246-251. PMID 28367810 DOI: 10.1051/Medsci/20173303010  0.454
2017 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Mitophagy: Permitted by Prohibitin. Current Biology : Cb. 27: R73-R76. PMID 28118594 DOI: 10.1016/J.Cub.2016.11.055  0.413
2017 López-Soto A, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Gonzalez S. Involvement of autophagy in NK cell development and function. Autophagy. 0. PMID 28103115 DOI: 10.1080/15548627.2016.1274486  0.561
2017 Gandhi S, Pabla S, Nesline M, Pandey M, Ernstoff MS, Dy GK, Conroy JM, Glenn S, Burgher B, Qin M, Andreas J, Giamo V, Papanicolau-Sengos A, Galluzzi L, He J, et al. Algorithmic prediction of response to checkpoint inhibitors: Hyperprogressors versus responders. Journal of Clinical Oncology. 35: 11565-11565. DOI: 10.1200/Jco.2017.35.15_Suppl.11565  0.324
2016 Galluzzi L, Kepp O, Kroemer G. Mitochondrial regulation of cell death: a phylogenetically conserved control. Microbial Cell (Graz, Austria). 3: 101-108. PMID 28357340 DOI: 10.15698/Mic2016.03.483  0.514
2016 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: The complement system is also important in immunogenic cell death. Nature Reviews. Immunology. PMID 28028312 DOI: 10.1038/Nri.2016.143  0.525
2016 Mondragón L, Kroemer G, Galluzzi L. Immunosuppressive γδ T cells foster pancreatic carcinogenesis. Oncoimmunology. 5: e1237328. PMID 27999755 DOI: 10.1080/2162402X.2016.1237328  0.422
2016 Kroemer G, Galluzzi L. Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors. Oncotarget. PMID 27974686 DOI: 10.18632/Oncotarget.13892  0.494
2016 Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: Mechanisms and Relevance to Disease. Annual Review of Pathology. PMID 27959630 DOI: 10.1146/Annurev-Pathol-052016-100247  0.488
2016 Paluch BE, Glenn ST, Conroy JM, Papanicolau-Sengos A, Bshara W, Omilian AR, Brese E, Nesline M, Burgher B, Andreas J, Odunsi K, Eng K, He J, Qin M, Gardner M, ... Galluzzi L, et al. Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing. Oncotarget. PMID 27911273 DOI: 10.18632/Oncotarget.13691  0.303
2016 Galluzzi L, Pedro JM, Demaria S, Formenti SC, Kroemer G. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nature Reviews. Clinical Oncology. PMID 27845767 DOI: 10.1038/Nrclinonc.2016.183  0.554
2016 Galluzzi L, Zitvogel L, Kroemer G. Immunological Mechanisms Underneath the Efficacy of Cancer Therapy. Cancer Immunology Research. 4: 895-902. PMID 27803050 DOI: 10.1158/2326-6066.Cir-16-0197  0.496
2016 Fucikova J, Truxova I, Hensler M, Becht E, Kasikova L, Moserova I, Vosahlikova S, Klouckova J, Church SE, Cremer I, Kepp O, Kroemer G, Galluzzi L, Salek C, Spisek R. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood. PMID 27802968 DOI: 10.1182/Blood-2016-08-731737  0.519
2016 Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, ... Galluzzi L, et al. Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 5: e1214790. PMID 27757313 DOI: 10.1080/2162402X.2016.1214790  0.7
2016 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nature Reviews. Immunology. PMID 27748397 DOI: 10.1038/Nri.2016.107  0.576
2016 Galluzzi L. Novel Insights into PML-Dependent Oncosuppression. Trends in Cell Biology. 26: 889-890. PMID 27663133 DOI: 10.1016/J.Tcb.2016.09.001  0.387
2016 Galluzzi L, Kroemer G. Aberrant ketolysis fuels hepatocellular cancer progression. Cell Research. 26: 1077-1078. PMID 27644988 DOI: 10.1038/Cr.2016.110  0.477
2016 López-Otín C, Galluzzi L, Freije JM, Madeo F, Kroemer G. Metabolic Control of Longevity. Cell. 166: 802-21. PMID 27518560 DOI: 10.1016/J.Cell.2016.07.031  0.361
2016 Buqué A, Bloy N, Aranda F, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 5: e1149674. PMID 27471617 DOI: 10.1080/2162402X.2016.1149674  0.54
2016 Kroemer G, Galluzzi L, Zitvogel L. STAT3 inhibition for cancer therapy: Cell-autonomous effects only? Oncoimmunology. 5: e1126063. PMID 27467938 DOI: 10.1080/2162402X.2015.1126063  0.584
2016 Galluzzi L, Buqué A, Kroemer G. Prevention of breast cancer by RANKL/RANK blockade. Cell Research. 26: 751-2. PMID 27325297 DOI: 10.1038/Cr.2016.79  0.395
2016 Galluzzi L, Bravo-San Pedro JM, Blomgren K, Kroemer G. Autophagy in acute brain injury. Nature Reviews. Neuroscience. 17: 467-84. PMID 27256553 DOI: 10.1038/Nrn.2016.51  0.439
2016 Sica V, Manic G, Kroemer G, Vitale I, Galluzzi L. Cytofluorometric Quantification of Cell Death Elicited by NLR Proteins. Methods in Molecular Biology (Clifton, N.J.). 1417: 231-45. PMID 27221495 DOI: 10.1007/978-1-4939-3566-6_17  0.674
2016 Galluzzi L, Kroemer G. A four-lane highway to cancer. Nature Reviews. Molecular Cell Biology. 17: 398. PMID 27220642 DOI: 10.1038/Nrm.2016.73  0.412
2016 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Defective Autophagy Initiates Malignant Transformation. Molecular Cell. 62: 473-4. PMID 27203173 DOI: 10.1016/J.Molcel.2016.05.001  0.414
2016 Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L. Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties. Trends in Cell Biology. 26: 655-67. PMID 27161573 DOI: 10.1016/J.Tcb.2016.04.006  0.66
2016 Iribarren K, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Špíšek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 5: e1088631. PMID 27141345 DOI: 10.1080/2162402X.2015.1088631  0.472
2016 Sica V, Maiuri MC, Kroemer G, Galluzzi L. Detection of Apoptotic Versus Autophagic Cell Death by Flow Cytometry. Methods in Molecular Biology (Clifton, N.J.). 1419: 1-16. PMID 27108427 DOI: 10.1007/978-1-4939-3581-9_1  0.713
2016 Galluzzi L, Kroemer G. Amino acid deprivation promotes intestinal homeostasis through autophagy. Oncotarget. 7: 29877-8. PMID 27105494 DOI: 10.18632/Oncotarget.8841  0.527
2016 Pol J, Buqué A, Aranda F, Bloy N, Cremer I, Eggermont A, Erbs P, Fucikova J, Galon J, Limacher JM, Preville X, Sautès-Fridman C, Spisek R, Zitvogel L, Kroemer G, ... Galluzzi L, et al. Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 5: e1117740. PMID 27057469 DOI: 10.1080/2162402X.2015.1117740  0.373
2016 Vacchelli E, Aranda F, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 5: e1115942. PMID 27057468 DOI: 10.1080/2162402X.2015.1115942  0.706
2016 Galluzzi L, Bravo-San Pedro JM, Kepp O, Kroemer G. Regulated cell death and adaptive stress responses. Cellular and Molecular Life Sciences : Cmls. 73: 2405-10. PMID 27048813 DOI: 10.1007/S00018-016-2209-Y  0.531
2016 Pol J, Kroemer G, Galluzzi L. First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology. 5: e1115641. PMID 26942095 DOI: 10.1080/2162402X.2015.1115641  0.372
2016 Galluzzi L, Eggermont A, Kroemer G. Doubling the blockade for melanoma immunotherapy. Oncoimmunology. 5: e1106127. PMID 26942094 DOI: 10.1080/2162402X.2015.1106127  0.382
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin J, Abeliovich H, Arozena AA, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Galluzzi L, ... ... Galluzzi L, et al. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Autophagy. 12: 443-443. PMID 26902590 DOI: 10.1080/15548627.2016.1147886  0.758
2016 Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity. 44: 221-31. PMID 26885855 DOI: 10.1016/J.Immuni.2016.01.020  0.537
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Galluzzi L, ... ... Galluzzi L, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.8
2016 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Autophagy Mediates Tumor Suppression via Cellular Senescence. Trends in Cell Biology. 26: 1-3. PMID 26612212 DOI: 10.1016/J.Tcb.2015.11.001  0.546
2016 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Ferroptosis in p53-dependent oncosuppression and organismal homeostasis. Cell Death and Differentiation. 22: 1237-8. PMID 26143748 DOI: 10.1038/Cdd.2015.54  0.486
2016 Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis Immunity. 44: 221-231. DOI: 10.1016/j.immuni.2016.01.020  0.413
2015 Vitale I, Manic G, Senovilla L, Kroemer G, Galluzzi L. Karyotypic Aberrations in Oncogenesis and Cancer Therapy. Trends in Cancer. 1: 124-135. PMID 28741522 DOI: 10.1016/J.Trecan.2015.08.001  0.534
2015 Obrist F, Manic G, Kroemer G, Vitale I, Galluzzi L. Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology. 2: e974463. PMID 27308423 DOI: 10.4161/23723556.2014.974463  0.524
2015 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell. 28: 690-714. PMID 26678337 DOI: 10.1016/J.Ccell.2015.10.012  0.512
2015 Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, et al. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology. 6: 588. PMID 26635802 DOI: 10.3389/Fimmu.2015.00588  0.754
2015 Galluzzi L, Kroemer G. Defective autophagy gets to the brain. Oncotarget. 6: 39396-7. PMID 26575951 DOI: 10.18632/Oncotarget.6318  0.522
2015 Galluzzi L, Pietrocola F, Kroemer G. Molecular Regulation of Circadian Rhythms by Polyamines. Cell Metabolism. 22: 757-8. PMID 26536485 DOI: 10.1016/J.Cmet.2015.10.007  0.652
2015 Aranda F, Buqué A, Bloy N, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 4: e1046673. PMID 26451319 DOI: 10.1080/2162402X.2015.1046673  0.543
2015 Kroemer G, Senovilla L, Galluzzi L, André F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nature Medicine. 21: 1128-38. PMID 26444637 DOI: 10.1038/Nm.3944  0.502
2015 Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology. 6: 402. PMID 26300886 DOI: 10.3389/Fimmu.2015.00402  0.55
2015 Sica V, Galluzzi L, Bravo-San Pedro JM, Izzo V, Maiuri MC, Kroemer G. Organelle-Specific Initiation of Autophagy. Molecular Cell. 59: 522-39. PMID 26295960 DOI: 10.1016/J.Molcel.2015.07.021  0.67
2015 Kroemer G, Galluzzi L. Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma. Oncoimmunology. 4: e1008853. PMID 26155425 DOI: 10.1080/2162402X.2015.1008853  0.479
2015 Bloy N, Buqué A, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 4: e1026531. PMID 26155408 DOI: 10.1080/2162402X.2015.1026531  0.45
2015 Kroemer G, Galluzzi L, Zitvogel L, Fridman WH. Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy? Oncoimmunology. 4: e1058597. PMID 26140250 DOI: 10.1080/2162402X.2015.1058597  0.429
2015 Kroemer G, Galluzzi L. Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-An exclamation sign with a question mark. Oncoimmunology. 4: e1058037. PMID 26140249 DOI: 10.1080/2162402X.2015.1058037  0.432
2015 Pol J, Bloy N, Buqué A, Eggermont A, Cremer I, Sautès-Fridman C, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 4: e974411. PMID 26137405 DOI: 10.4161/2162402X.2014.974411  0.365
2015 Pol J, Vacchelli E, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology. 4: e1008866. PMID 26137404 DOI: 10.1080/2162402X.2015.1008866  0.737
2015 Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 4: e1008814. PMID 26137403 DOI: 10.1080/2162402X.2015.1008814  0.489
2015 Enot DP, Niso-Santano M, Durand S, Chery A, Pietrocola F, Vacchelli E, Madeo F, Galluzzi L, Kroemer G. Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo. Cell Cycle (Georgetown, Tex.). 14: 2399-407. PMID 26098646 DOI: 10.1080/15384101.2015.1064206  0.757
2015 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Necrosis: Linking the Inflammasome to Inflammation. Cell Reports. 11: 1501-2. PMID 26082972 DOI: 10.1016/J.Celrep.2015.05.041  0.455
2015 Bezu L, Gomes-da-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death". Frontiers in Immunology. 6: 275. PMID 26082782 DOI: 10.3389/Fimmu.2015.00275  0.472
2015 Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metabolism. 21: 805-21. PMID 26039447 DOI: 10.1016/J.Cmet.2015.05.014  0.658
2015 Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nature Reviews. Immunology. 15: 405-14. PMID 26027717 DOI: 10.1038/Nri3845  0.46
2015 Bezu L, Gomes-de-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Combinatorial strategies for the induction of immunogenic cell death. Frontiers in Immunology. 6: 187. PMID 25964783 DOI: 10.3389/Fimmu.2015.00187  0.581
2015 Vacchelli E, Pol J, Bloy N, Eggermont A, Cremer I, Fridman WH, Galon J, Marabelle A, Kohrt H, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 4: e985940. PMID 25949870 DOI: 10.4161/2162402X.2014.985940  0.721
2015 Sauvat A, Wang Y, Segura F, Spaggiari S, Müller K, Zhou H, Galluzzi L, Kepp O, Kroemer G. Quantification of cellular viability by automated microscopy and flow cytometry. Oncotarget. 6: 9467-75. PMID 25816366 DOI: 10.18632/Oncotarget.3266  0.644
2015 Bonora M, Wieckowsk MR, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, Pinton P. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 34: 1608. PMID 25790189 DOI: 10.1038/Onc.2014.462  0.453
2015 Kroemer G, Bravo-San Pedro JM, Galluzzi L. Novel function of cytoplasmic p53 at the interface between mitochondria and the endoplasmic reticulum. Cell Death & Disease. 6: e1698. PMID 25789973 DOI: 10.1038/Cddis.2015.70  0.437
2015 Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buqué A, Huang X, Zhou H, Senovilla L, Kroemer G, Galluzzi L. eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in Cancer Biology. PMID 25749194 DOI: 10.1016/J.Semcancer.2015.02.004  0.554
2015 Niso-Santano M, Bravo-San Pedro JM, Maiuri MC, Tavernarakis N, Cecconi F, Madeo F, Codogno P, Galluzzi L, Kroemer G. Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy. 11: 575-7. PMID 25714112 DOI: 10.1080/15548627.2015.1017222  0.414
2015 Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A, Kumar S, Levine B, Maiuri MC, Martin SJ, et al. Autophagy in malignant transformation and cancer progression. The Embo Journal. 34: 856-80. PMID 25712477 DOI: 10.15252/Embj.201490784  0.743
2015 Zitvogel L, Galluzzi L, Viaud S, Vétizou M, Daillère R, Merad M, Kroemer G. Cancer and the gut microbiota: an unexpected link. Science Translational Medicine. 7: 271ps1. PMID 25609166 DOI: 10.1126/Scitranslmed.3010473  0.445
2015 Niso-Santano M, Malik SA, Pietrocola F, Bravo-San Pedro JM, Mariño G, Cianfanelli V, Ben-Younès A, Troncoso R, Markaki M, Sica V, Izzo V, Chaba K, Bauvy C, Dupont N, Kepp O, ... ... Galluzzi L, et al. Unsaturated fatty acids induce non-canonical autophagy. The Embo Journal. 34: 1025-41. PMID 25586377 DOI: 10.15252/Embj.201489363  0.822
2015 Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death and Differentiation. 22: 58-73. PMID 25236395 DOI: 10.1038/Cdd.2014.137  0.557
2014 Manic G, Obrist F, Kroemer G, Vitale I, Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Molecular & Cellular Oncology. 1: e29911. PMID 27308318 DOI: 10.4161/Mco.29911  0.562
2014 Galluzzi L, Kroemer G. Molecular and Cellular Oncology: A new journal for a changing field. Molecular & Cellular Oncology. 1: e29052. PMID 27308308 DOI: 10.4161/Mco.29052  0.562
2014 Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, ... ... Galluzzi L, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 3: e955691. PMID 25941621 DOI: 10.4161/21624011.2014.955691  0.837
2014 Aranda F, Bloy N, Galluzzi L, Kroemer G, Senovilla L. Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. Oncoimmunology. 3: e955685. PMID 25941619 DOI: 10.4161/21624011.2014.955685  0.498
2014 Bloy N, Pol J, Manic G, Vitale I, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology. 3: e954929. PMID 25941606 DOI: 10.4161/21624011.2014.954929  0.46
2014 Galluzzi L, Kroemer G, Eggermont A. Novel immune checkpoint blocker approved for the treatment of advanced melanoma. Oncoimmunology. 3: e967147. PMID 25941597 DOI: 10.4161/21624011.2014.967147  0.463
2014 Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 3: e963424. PMID 25941593 DOI: 10.4161/21624011.2014.963424  0.422
2014 Vacchelli E, Aranda F, Eggermont A, Sautès-Fridman C, Tartour E, Kennedy EP, Platten M, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 3: e957994. PMID 25941578 DOI: 10.4161/21624011.2014.957994  0.71
2014 Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 DOI: 10.18632/Oncotarget.2998  0.698
2014 Bonora M, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Pinton P. Novel insights into the mitochondrial permeability transition. Cell Cycle (Georgetown, Tex.). 13: 2666-70. PMID 25486353 DOI: 10.4161/15384101.2014.949082  0.443
2014 Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell. 159: 1263-76. PMID 25480292 DOI: 10.1016/J.Cell.2014.11.006  0.668
2014 Green DR, Galluzzi L, Kroemer G. Cell biology. Metabolic control of cell death. Science (New York, N.Y.). 345: 1250256. PMID 25237106 DOI: 10.1126/Science.1250256  0.512
2014 Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Cremer I, Erbs P, Limacher JM, Preville X, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 3: e28694. PMID 25097804 DOI: 10.4161/Onci.28694  0.522
2014 Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Henrik Ter Meulen J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in oncological indications. Oncoimmunology. 3: e29179. PMID 25083332 DOI: 10.4161/Onci.29179  0.688
2014 Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology. 3: e29030. PMID 25083328 DOI: 10.4161/Onci.29030  0.713
2014 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Organelle-specific initiation of cell death. Nature Cell Biology. 16: 728-36. PMID 25082195 DOI: 10.1038/Ncb3005  0.542
2014 Sukkurwala AQ, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco EE, Galluzzi L, Zitvogel L, Kepp O, Kroemer G. Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. Oncoimmunology. 3: e28473. PMID 25050214 DOI: 10.4161/Onci.28473  0.839
2014 Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 3: e28344. PMID 25050207 DOI: 10.4161/onci.28344  0.672
2014 Senovilla L, Aranda F, Galluzzi L, Kroemer G. Impact of myeloid cells on the efficacy of anticancer chemotherapy. Current Opinion in Immunology. 30: 24-31. PMID 24950501 DOI: 10.1016/J.Coi.2014.05.009  0.561
2014 Galluzzi L, Kroemer G. Preface: oncometabolism: a new field of research with profound therapeutic implications. Methods in Enzymology. 543: xv-xix. PMID 24924141 DOI: 10.1016/B978-0-12-801329-8.10000-5  0.344
2014 Scoazec M, Durand S, Chery A, Galluzzi L, Kroemer G. Metabolomic profiling of cultured cancer cells. Methods in Enzymology. 543: 165-78. PMID 24924132 DOI: 10.1016/B978-0-12-801329-8.00008-8  0.461
2014 Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G. Systems biology of cisplatin resistance: past, present and future. Cell Death & Disease. 5: e1257. PMID 24874729 DOI: 10.1038/Cddis.2013.428  0.765
2014 Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: DNA vaccines for cancer therapy. Oncoimmunology. 3: e28185. PMID 24800178 DOI: 10.4161/Onci.28185  0.476
2014 Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 3: e27878. PMID 24800173 DOI: 10.4161/Onci.27878  0.743
2014 Ma Y, Adjemian S, Galluzzi L, Zitvogel L, Kroemer G. Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy. Oncoimmunology. 3: e27663. PMID 24800170 DOI: 10.4161/Onci.27663  0.724
2014 Bonora M, Wieckowski MR, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, Pinton P. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 34: 1475-86. PMID 24727893 DOI: 10.1038/Onc.2014.96  0.503
2014 Aranda F, Vacchelli E, Eggermont A, Galon J, Fridman WH, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology. 3: e27297. PMID 24701370 DOI: 10.4161/Onci.27297  0.696
2014 Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy. Oncoimmunology. 3: e27048. PMID 24605265 DOI: 10.4161/Onci.27048  0.698
2014 Galluzzi L, Kepp O, Krautwald S, Kroemer G, Linkermann A. Molecular mechanisms of regulated necrosis. Seminars in Cell & Developmental Biology. 35: 24-32. PMID 24582829 DOI: 10.1016/J.Semcdb.2014.02.006  0.53
2014 Galluzzi L, Kepp O, Kroemer G. MLKL regulates necrotic plasma membrane permeabilization. Cell Research. 24: 139-40. PMID 24418759 DOI: 10.1038/Cr.2014.8  0.395
2014 Ma Y, Mattarollo SR, Adjemian S, Yang H, Aymeric L, Hannani D, Portela Catani JP, Duret H, Teng MW, Kepp O, Wang Y, Sistigu A, Schultze JL, Stoll G, Galluzzi L, et al. CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. Cancer Research. 74: 436-45. PMID 24302580 DOI: 10.1158/0008-5472.Can-13-1265  0.817
2014 Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, Kepp O, Métivier D, Galluzzi L, Perfettini JL, Zitvogel L, Kroemer G. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death and Differentiation. 21: 79-91. PMID 23852373 DOI: 10.1038/cdd.2013.75  0.811
2014 Sukkurwala AQ, Martins I, Wang Y, Schlemmer F, Ruckenstuhl C, Durchschlag M, Michaud M, Senovilla L, Sistigu A, Ma Y, Vacchelli E, Sulpice E, Gidrol X, Zitvogel L, Madeo F, ... Galluzzi L, et al. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. Cell Death and Differentiation. 21: 59-68. PMID 23787997 DOI: 10.1038/Cdd.2013.73  0.828
2014 Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, Vicencio JM, Soussi T, Kroemer G. Erratum to Morselli E, et al. Cell Cycle 2008; 7:3056–61 Cell Cycle. 13: 2311-2311. DOI: 10.4161/Cc.29672  0.773
2014 Michels J, Goubar A, Adam J, Galluzzi L, Olaussen KA, Robin A, Girard P, Kremer I, Castedo M, Soria J, Kroemer G. Abstract 4691: Overactivation of poly (ADP-ribose) polymerase (PARP) in localised non-small cell lung cancer (NSCLC) predicts dismal prognosis Cancer Research. 74: 4691-4691. DOI: 10.1158/1538-7445.Am2014-4691  0.706
2013 Kroemer G, Galluzzi L, Zitvogel L. Immunological effects of chemotherapy in spontaneous breast cancers. Oncoimmunology. 2: e27158. PMID 24498568 DOI: 10.4161/Onci.27158  0.499
2013 Aranda F, Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide vaccines in cancer therapy. Oncoimmunology. 2: e26621. PMID 24498550 DOI: 10.4161/onci.26621  0.661
2013 Semeraro M, Vacchelli E, Eggermont A, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Lenalidomide-based immunochemotherapy. Oncoimmunology. 2: e26494. PMID 24482747 DOI: 10.4161/Onci.26494  0.706
2013 Kepp O, Galluzzi L, Kroemer G. Immune effectors required for the therapeutic activity of vorinostat. Oncoimmunology. 2: e27157. PMID 24475375 DOI: 10.4161/Onci.27157  0.537
2013 Galluzzi L, Kepp O, Kroemer G. Immunogenic cell death in radiation therapy. Oncoimmunology. 2: e26536. PMID 24404424 DOI: 10.4161/Onci.26536  0.603
2013 Vacchelli E, Vitale I, Tartour E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Anticancer radioimmunotherapy. Oncoimmunology. 2: e25595. PMID 24319634 DOI: 10.4161/Onci.25595  0.741
2013 Vacchelli E, Vitale I, Eggermont A, Fridman WH, Fučíková J, Cremer I, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology. 2: e25771. PMID 24286020 DOI: 10.4161/onci.25771  0.666
2013 Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G. Metabolic targets for cancer therapy. Nature Reviews. Drug Discovery. 12: 829-46. PMID 24113830 DOI: 10.1038/Nrd4145  0.449
2013 Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2: e25238. PMID 24083080 DOI: 10.4161/Onci.25238  0.668
2013 Vacchelli E, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 2: e24850. PMID 24073369 DOI: 10.4161/Onci.24850  0.705
2013 Galluzzi L, Kroemer G. Common and divergent functions of Beclin 1 and Beclin 2. Cell Research. 23: 1341-2. PMID 24018378 DOI: 10.1038/Cr.2013.129  0.42
2013 Wang Y, Martins I, Ma Y, Kepp O, Galluzzi L, Kroemer G. Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy. 9: 1624-5. PMID 23989612 DOI: 10.4161/Auto.25873  0.667
2013 Lainey E, Wolfromm A, Sukkurwala AQ, Micol JB, Fenaux P, Galluzzi L, Kepp O, Kroemer G. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell Cycle (Georgetown, Tex.). 12: 2978-91. PMID 23974111 DOI: 10.4161/Cc.26016  0.814
2013 Ma Y, Galluzzi L, Zitvogel L, Kroemer G. Autophagy and cellular immune responses. Immunity. 39: 211-27. PMID 23973220 DOI: 10.1016/J.Immuni.2013.07.017  0.562
2013 Jemaà M, Galluzzi L, Kepp O, Senovilla L, Brands M, Boemer U, Koppitz M, Lienau P, Prechtl S, Schulze V, Siemeister G, Wengner AM, Mumberg D, Ziegelbauer K, Abrieu A, et al. Characterization of novel MPS1 inhibitors with preclinical anticancer activity. Cell Death and Differentiation. 20: 1532-45. PMID 23933817 DOI: 10.1038/Cdd.2013.105  0.535
2013 Spaggiari S, Kepp O, Rello-Varona S, Chaba K, Adjemian S, Pype J, Galluzzi L, Lemaire M, Kroemer G. Antiapoptotic activity of argon and xenon. Cell Cycle (Georgetown, Tex.). 12: 2636-42. PMID 23907115 DOI: 10.4161/Cc.25650  0.768
2013 Vacchelli E, Prada N, Kepp O, Galluzzi L. Current trends of anticancer immunochemotherapy. Oncoimmunology. 2: e25396. PMID 23894726 DOI: 10.4161/Onci.25396  0.639
2013 Ma Y, Yamazaki T, Yang H, Kepp O, Galluzzi L, Zitvogel L, Smyth MJ, Kroemer G. Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy. Oncoimmunology. 2: e24786. PMID 23894723 DOI: 10.4161/Onci.24786  0.475
2013 Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Oncolytic viruses for cancer therapy. Oncoimmunology. 2: e24612. PMID 23894720 DOI: 10.4161/onci.24612  0.671
2013 Ma Y, Adjemian S, Yang H, Catani JP, Hannani D, Martins I, Michaud M, Kepp O, Sukkurwala AQ, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G. ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy. Oncoimmunology. 2: e24568. PMID 23894718 DOI: 10.4161/Onci.24568  0.809
2013 Senovilla L, Galluzzi L, Zitvogel L, Kroemer G. Immunosurveillance as a regulator of tissue homeostasis. Trends in Immunology. 34: 471-81. PMID 23891238 DOI: 10.1016/J.It.2013.06.005  0.456
2013 Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity. 39: 74-88. PMID 23890065 DOI: 10.1016/J.Immuni.2013.06.014  0.544
2013 Mavilio D, Galluzzi L, Lugli E. Novel multifunctional antibody approved for the treatment of breast cancer. Oncoimmunology. 2: e24567. PMID 23802090 DOI: 10.4161/Onci.24567  0.396
2013 Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala AQ, Michaud M, Senovilla L, Galluzzi L, Kroemer G, Zitvogel L. Crosstalk between ER stress and immunogenic cell death. Cytokine & Growth Factor Reviews. 24: 311-8. PMID 23787159 DOI: 10.1016/J.Cytogfr.2013.05.001  0.817
2013 Vacchelli E, Eggermont A, Fridman WH, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 2: e24238. PMID 23762803 DOI: 10.4161/Onci.24238  0.723
2013 Galluzzi L, Lugli E. Cancer immunotherapy turns viral. Oncoimmunology. 2: e24802. PMID 23734338 DOI: 10.4161/Onci.24802  0.455
2013 Senovilla L, Vacchelli E, Garcia P, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: DNA vaccines for cancer therapy. Oncoimmunology. 2: e23803. PMID 23734328 DOI: 10.4161/onci.23803  0.647
2013 Martins I, Kepp O, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Vacchelli E, Galluzzi L, Kroemer G. Fluorescent biosensors for the detection of HMGB1 release. Methods in Molecular Biology (Clifton, N.J.). 1004: 43-56. PMID 23733568 DOI: 10.1007/978-1-62703-383-1_4  0.823
2013 Pietrocola F, Izzo V, Niso-Santano M, Vacchelli E, Galluzzi L, Maiuri MC, Kroemer G. Regulation of autophagy by stress-responsive transcription factors. Seminars in Cancer Biology. 23: 310-22. PMID 23726895 DOI: 10.1016/J.Semcancer.2013.05.008  0.788
2013 Vacchelli E, Senovilla L, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 2: e23510. PMID 23687621 DOI: 10.4161/onci.23510  0.704
2013 Senovilla L, Galluzzi L, Castedo M, Kroemer G. Immunological control of cell cycle aberrations for the avoidance of oncogenesis: the case of tetraploidy. Annals of the New York Academy of Sciences. 1284: 57-61. PMID 23651194 DOI: 10.1111/Nyas.12072  0.567
2013 Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. Journal of Hepatology. 59: 583-94. PMID 23567086 DOI: 10.1016/J.Jhep.2013.03.033  0.482
2013 Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, Martins I, Schlemmer F, Michaud M, Kepp O, Sukkurwala AQ, ... ... Galluzzi L, et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 38: 729-41. PMID 23562161 DOI: 10.1016/J.Immuni.2013.03.003  0.837
2013 Michels J, Vitale I, Galluzzi L, Adam J, Olaussen KA, Kepp O, Senovilla L, Talhaoui I, Guegan J, Enot DP, Talbot M, Robin A, Girard P, Oréar C, Lissa D, et al. Cisplatin resistance associated with PARP hyperactivation. Cancer Research. 73: 2271-80. PMID 23554447 DOI: 10.1158/0008-5472.Can-12-3000  0.84
2013 Michels J, Kepp O, Senovilla L, Lissa D, Castedo M, Kroemer G, Galluzzi L. Functions of BCL-X L at the Interface between Cell Death and Metabolism. International Journal of Cell Biology. 2013: 705294. PMID 23533418 DOI: 10.1155/2013/705294  0.822
2013 Galluzzi L, Lugli E. Rejuvenated T cells attack old tumors. Oncoimmunology. 2: e24103. PMID 23526137 DOI: 10.4161/Onci.24103  0.411
2013 Menger L, Vacchelli E, Kepp O, Eggermont A, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Cardiac glycosides and cancer therapy. Oncoimmunology. 2: e23082. PMID 23525565 DOI: 10.4161/Onci.23082  0.79
2013 Senovilla L, Vitale I, Martins I, Kepp O, Galluzzi L, Zitvogel L, Castedo M, Kroemer G. An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells. Oncoimmunology. 2: e22409. PMID 23482968 DOI: 10.4161/Onci.22409  0.535
2013 Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Monoclonal antibodies in cancer therapy. Oncoimmunology. 2: e22789. PMID 23482847 DOI: 10.4161/onci.22789  0.672
2013 Bonora M, Bononi A, De Marchi E, Giorgi C, Lebiedzinska M, Marchi S, Patergnani S, Rimessi A, Suski JM, Wojtala A, Wieckowski MR, Kroemer G, Galluzzi L, Pinton P. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle (Georgetown, Tex.). 12: 674-83. PMID 23343770 DOI: 10.4161/Cc.23599  0.463
2013 Galluzzi L, Goubar A, Olaussen KA, Vitale I, Senovilla L, Michels J, Robin A, Dorvault N, Besse B, Validire P, Fouret P, Behrens C, Wistuba II, Soria JC, Kroemer G. Prognostic value of LIPC in non-small cell lung carcinoma. Cell Cycle (Georgetown, Tex.). 12: 647-54. PMID 23343765 DOI: 10.4161/Cc.23517  0.715
2013 Galluzzi L, Vacchelli E, Michels J, Garcia P, Kepp O, Senovilla L, Vitale I, Kroemer G. Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses. Oncogene. 32: 4995-5004. PMID 23334322 DOI: 10.1038/Onc.2012.623  0.783
2013 Boilève A, Senovilla L, Vitale I, Lissa D, Martins I, Métivier D, van den Brink S, Clevers H, Galluzzi L, Castedo M, Kroemer G. Immunosurveillance against tetraploidization-induced colon tumorigenesis. Cell Cycle (Georgetown, Tex.). 12: 473-9. PMID 23324343 DOI: 10.4161/Cc.23369  0.796
2013 Kepp O, Martins I, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Galluzzi L, Kroemer G. Quantification of cell cycle-arresting proteins. Methods in Molecular Biology (Clifton, N.J.). 965: 121-42. PMID 23296654 DOI: 10.1007/978-1-62703-239-1_7  0.815
2013 Vitale I, Jemaà M, Galluzzi L, Metivier D, Castedo M, Kroemer G. Cytofluorometric assessment of cell cycle progression. Methods in Molecular Biology (Clifton, N.J.). 965: 93-120. PMID 23296653 DOI: 10.1007/978-1-62703-239-1_6  0.754
2013 Galluzzi L, Marsili S, Vitale I, Senovilla L, Michels J, Garcia P, Vacchelli E, Chatelut E, Castedo M, Kroemer G. Vitamin B6 metabolism influences the intracellular accumulation of cisplatin. Cell Cycle (Georgetown, Tex.). 12: 417-21. PMID 23287530 DOI: 10.4161/Cc.23275  0.807
2013 Jemaà M, Galluzzi L, Kepp O, Castedo M, Rello-Varona S, Vitale I, Kroemer G. Transgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterations. Cell Cycle (Georgetown, Tex.). 12: 183-90. PMID 23255111 DOI: 10.4161/Cc.23046  0.77
2013 Niso-Santano M, Shen S, Adjemian S, Malik SA, Mariño G, Lachkar S, Senovilla L, Kepp O, Galluzzi L, Maiuri MC, Kroemer G. Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy. Autophagy. 9: 415-7. PMID 23221979 DOI: 10.4161/Auto.22910  0.804
2013 Galluzzi L, Kepp O, Kroemer G. Mitochondria: master regulators of danger signalling. Nature Reviews. Molecular Cell Biology. 13: 780-8. PMID 23175281 DOI: 10.1038/Nrm3479  0.505
2013 Senovilla L, Galluzzi L, Marino G, Vitale I, Castedo M, Kroemer G. Immunosurveillance against cancer-associated hyperploidy. Oncotarget. 3: 1270-1. PMID 23174699 DOI: 10.18632/Oncotarget.753  0.596
2013 Lainey E, Wolfromm A, Marie N, Enot D, Scoazec M, Bouteloup C, Leroy C, Micol JB, De Botton S, Galluzzi L, Fenaux P, Kroemer G. Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. Oncogene. 32: 4331-42. PMID 23085751 DOI: 10.1038/Onc.2012.469  0.747
2013 Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Mitochondrial control of cellular life, stress, and death. Circulation Research. 111: 1198-207. PMID 23065343 DOI: 10.1161/Circresaha.112.268946  0.536
2013 Wengner A, Jemaà M, Galluzzi L, Kepp O, Brands M, Koppitz M, Schulze V, Siemeister G, Mumberg D, Ziegelbauer K, Castedo M, Vitale I, Kroemer G. Abstract 706: Novel MPS1 inhibitors with potential anticancer activity. Cancer Research. 73: 706-706. DOI: 10.1158/1538-7445.Am2013-706  0.76
2013 Galluzzi L, Kepp O, Heiden MGV, Kroemer G. Erratum: Metabolic targets for cancer therapy Nature Reviews Drug Discovery. 12: 963-963. DOI: 10.1038/Nrd4191  0.432
2013 Criollo A, Galluzzi L, Chiara Maiuri M, Tasdemir E, Lavandero S, Kroemer G. Erratum to: Mitochondrial control of cell death induced by hyperosmotic stress Apoptosis. 18: 535-536. DOI: 10.1007/S10495-013-0817-7  0.742
2012 Kepp O, Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Sukkurwala AQ, Michaud M, Galluzzi L, Zitvogel L, Kroemer G. Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects. Oncoimmunology. 1: 1640-1642. PMID 23264921 DOI: 10.4161/Onci.21684  0.815
2012 Vacchelli E, Martins I, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Peptide vaccines in cancer therapy. Oncoimmunology. 1: 1557-1576. PMID 23264902 DOI: 10.4161/Onci.22428  0.681
2012 Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 1: 1323-1343. PMID 23243596 DOI: 10.4161/Onci.22009  0.823
2012 Galluzzi L, Senovilla L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology. 1: 1111-1134. PMID 23170259 DOI: 10.4161/Onci.21494  0.692
2012 Vacchelli E, Galluzzi L, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. Oncoimmunology. 1: 894-907. PMID 23162757 DOI: 10.4161/Onci.20931  0.684
2012 Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annual Review of Immunology. 31: 51-72. PMID 23157435 DOI: 10.1146/Annurev-Immunol-032712-100008  0.579
2012 Tanchot C, Terme M, Pere H, Tran T, Benhamouda N, Strioga M, Banissi C, Galluzzi L, Kroemer G, Tartour E. Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 6: 147-57. PMID 23104434 DOI: 10.1007/S12307-012-0122-Y  0.519
2012 Lainey E, Sébert M, Thépot S, Scoazec M, Bouteloup C, Leroy C, De Botton S, Galluzzi L, Fenaux P, Kroemer G. Erlotinib antagonizes ABC transporters in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 11: 4079-92. PMID 23095522 DOI: 10.4161/Cc.22382  0.732
2012 Shen S, Niso-Santano M, Adjemian S, Takehara T, Malik SA, Minoux H, Souquere S, Mariño G, Lachkar S, Senovilla L, Galluzzi L, Kepp O, Pierron G, Maiuri MC, Hikita H, et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Molecular Cell. 48: 667-80. PMID 23084476 DOI: 10.1016/J.Molcel.2012.09.013  0.8
2012 Pietrocola F, Mariño G, Lissa D, Vacchelli E, Malik SA, Niso-Santano M, Zamzami N, Galluzzi L, Maiuri MC, Kroemer G. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle (Georgetown, Tex.). 11: 3851-60. PMID 23070521 DOI: 10.4161/Cc.22027  0.797
2012 Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, Shen S, Mariño G, Criollo A, Boilève A, Job B, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science (New York, N.Y.). 337: 1678-84. PMID 23019653 DOI: 10.1126/Science.1224922  0.835
2012 Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology. 1: 699-716. PMID 22934262 DOI: 10.4161/Onci.20696  0.697
2012 Galluzzi L, Vitale I, Senovilla L, Eisenberg T, Carmona-Gutierrez D, Vacchelli E, Robert T, Ripoche H, Jägemann N, Paccard C, Servant N, Hupé P, Lazar V, Dessen P, Barillot E, et al. Independent transcriptional reprogramming and apoptosis induction by cisplatin. Cell Cycle (Georgetown, Tex.). 11: 3472-80. PMID 22918244 DOI: 10.4161/Cc.21789  0.737
2012 Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, Goubar A, Martins I, Michels J, Kratassiouk G, Carmona-Gutierrez D, Scoazec M, Vacchelli E, Schlemmer F, Kepp O, et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Reports. 2: 257-69. PMID 22854025 DOI: 10.1016/J.Celrep.2012.06.017  0.796
2012 Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G, Schlemmer F, Sulpice E, Locher C, Gidrol X, Ghiringhelli F, ... ... Galluzzi L, et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Science Translational Medicine. 4: 143ra99. PMID 22814852 DOI: 10.1126/Scitranslmed.3003807  0.827
2012 Vacchelli E, Galluzzi L, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G. Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 1: 493-506. PMID 22754768 DOI: 10.4161/onci.20459  0.703
2012 Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Trial Watch: Adoptive cell transfer immunotherapy. Oncoimmunology. 1: 306-315. PMID 22737606 DOI: 10.4161/Onci.19549  0.735
2012 Vacchelli E, Galluzzi L, Rousseau V, Rigoni A, Tesniere A, Delahaye N, Schlemmer FD, Menger L, Sukkurwala AQ, Adjemian S, Martins I, Michaud M, Dunant A, Kepp O, Brambilla E, et al. Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer. Oncoimmunology. 1: 271-278. PMID 22737602 DOI: 10.4161/Onci.18684  0.808
2012 Vacchelli E, Galluzzi L, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Kroemer G. Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 1: 179-188. PMID 22720239 DOI: 10.4161/onci.1.2.19026  0.726
2012 Galluzzi L, Vacchelli E, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zucman-Rossi J, Zitvogel L, Kroemer G. Trial Watch: Monoclonal antibodies in cancer therapy. Oncoimmunology. 1: 28-37. PMID 22720209 DOI: 10.4161/Onci.1.1.17938  0.709
2012 Ladoire S, Chaba K, Martins I, Sukkurwala AQ, Adjemian S, Michaud M, Poirier-Colame V, Andreiuolo F, Galluzzi L, White E, Rosenfeldt M, Ryan KM, Zitvogel L, Kroemer G. Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy. 8: 1175-84. PMID 22647537 DOI: 10.4161/Auto.20353  0.812
2012 Jemaà M, Galluzzi L, Kepp O, Boilève A, Lissa D, Senovilla L, Harper F, Pierron G, Berardinelli F, Antoccia A, Castedo M, Vitale I, Kroemer G. Preferential killing of p53-deficient cancer cells by reversine. Cell Cycle (Georgetown, Tex.). 11: 2149-58. PMID 22592527 DOI: 10.4161/Cc.20621  0.834
2012 Galluzzi L, Kroemer G. Autophagy mediates the metabolic benefits of endurance training. Circulation Research. 110: 1276-8. PMID 22581920 DOI: 10.1161/Res.0B013E318259E70B  0.532
2012 Jemaà M, Vitale I, Kepp O, Berardinelli F, Galluzzi L, Senovilla L, Mariño G, Malik SA, Rello-Varona S, Lissa D, Antoccia A, Tailler M, Schlemmer F, Harper F, Pierron G, et al. Selective killing of p53-deficient cancer cells by SP600125. Embo Molecular Medicine. 4: 500-14. PMID 22438244 DOI: 10.1002/Emmm.201200228  0.818
2012 Zitvogel L, Kepp O, Galluzzi L, Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nature Immunology. 13: 343-51. PMID 22430787 DOI: 10.1038/Ni.2224  0.56
2012 Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Non-apoptotic functions of apoptosis-regulatory proteins. Embo Reports. 13: 322-30. PMID 22402666 DOI: 10.1038/Embor.2012.19  0.528
2012 Martins I, Michaud M, Sukkurwala AQ, Adjemian S, Ma Y, Shen S, Kepp O, Menger L, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy. 8: 413-5. PMID 22361584 DOI: 10.4161/Auto.19009  0.845
2012 Galluzzi L, Kepp O, Kroemer G. Reverse Warburg: straight to cancer. Cell Cycle (Georgetown, Tex.). 11: 1059. PMID 22343921 DOI: 10.4161/Cc.11.6.19746  0.417
2012 Niso-Santano M, Criollo A, Malik SA, Michaud M, Morselli E, Mariño G, Lachkar S, Galluzzi L, Maiuri MC, Kroemer G. Direct molecular interactions between Beclin 1 and the canonical NFκB activation pathway. Autophagy. 8: 268-70. PMID 22301997 DOI: 10.4161/Auto.8.2.18845  0.807
2012 Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs. Nature Reviews. Drug Discovery. 11: 215-33. PMID 22301798 DOI: 10.1038/Nrd3626  0.488
2012 Galluzzi L, Kepp O, Kroemer G. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. The Embo Journal. 31: 1055-7. PMID 22252132 DOI: 10.1038/Emboj.2012.2  0.514
2012 Galluzzi L, Kroemer G. Necroptosis turns TNF lethal. Immunity. 35: 849-51. PMID 22195740 DOI: 10.1016/J.Immuni.2011.12.004  0.44
2012 Criollo A, Chereau F, Malik SA, Niso-Santano M, Mariño G, Galluzzi L, Maiuri MC, Baud V, Kroemer G. Autophagy is required for the activation of NFκB. Cell Cycle (Georgetown, Tex.). 11: 194-9. PMID 22186785 DOI: 10.4161/Cc.11.1.18669  0.77
2012 Galluzzi L, Morselli E, Kepp O, Vitale I, Younes AB, Maiuri MC, Kroemer G. Evaluation of rapamycin-induced cell death. Methods in Molecular Biology (Clifton, N.J.). 821: 125-69. PMID 22125064 DOI: 10.1007/978-1-61779-430-8_9  0.756
2012 Hannani D, Sistigu A, Kepp O, Galluzzi L, Kroemer G, Zitvogel L. Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. Cancer Journal (Sudbury, Mass.). 17: 351-8. PMID 21952286 DOI: 10.1097/Ppo.0B013E3182325D4D  0.583
2012 Martins I, Galluzzi L, Kroemer G. Hormesis, cell death and aging. Aging. 3: 821-8. PMID 21931183 DOI: 10.18632/AGING.100380  0.416
2012 Galluzzi L, Vanden Berghe T, Vanlangenakker N, Buettner S, Eisenberg T, Vandenabeele P, Madeo F, Kroemer G. Programmed necrosis from molecules to health and disease. International Review of Cell and Molecular Biology. 289: 1-35. PMID 21749897 DOI: 10.1016/B978-0-12-386039-2.00001-8  0.504
2012 Criollo A, Chereau F, Malik SA, Niso-Santano M, Mariño G, Galluzzi L, Maiuri MC, Baud V, Kroemer G. Erratum to Criollo A, et al. Cell Cycle Volume 11, Issue 1; pp. 194-9 Cell Cycle. 11: 4673-4673. DOI: 10.4161/cc.23148  0.679
2012 Michels J, Vitale I, Galluzzi L, Kepp O, Senovilla L, Olaussen KA, Soria J, Castedo M, Kroemer G. Abstract 3115: PARP overactivation predicts the susceptibility of human cancer cells to apoptosis induction by PARP inhibitors Cancer Research. 72: 3115-3115. DOI: 10.1158/1538-7445.Am2012-3115  0.773
2011 Galluzzi L, Vitale I, Vacchelli E, Kroemer G. Cell death signaling and anticancer therapy. Frontiers in Oncology. 1: 5. PMID 22655227 DOI: 10.3389/Fonc.2011.00005  0.758
2011 Galluzzi L, Kroemer G. The grand challenges to cellular and molecular oncology. Frontiers in Oncology. 1: 2. PMID 22655225 DOI: 10.3389/Fonc.2011.00002  0.548
2011 Galluzzi L, Vitale I, Kroemer G. Past, present, and future of molecular and cellular oncology. Frontiers in Oncology. 1: 1. PMID 22655224 DOI: 10.3389/Fonc.2011.00001  0.549
2011 Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (New York, N.Y.). 334: 1573-7. PMID 22174255 DOI: 10.1126/Science.1208347  0.837
2011 Tailler M, Senovilla L, Lainey E, Thépot S, Métivier D, Sébert M, Baud V, Billot K, Fenaux P, Galluzzi L, Boehrer S, Kroemer G, Kepp O. Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene. 31: 3536-46. PMID 22105358 DOI: 10.1038/Onc.2011.521  0.837
2011 Criollo A, Niso-Santano M, Malik SA, Michaud M, Morselli E, Mariño G, Lachkar S, Arkhipenko AV, Harper F, Pierron G, Rain JC, Ninomiya-Tsuji J, Fuentes JM, Lavandero S, Galluzzi L, et al. Inhibition of autophagy by TAB2 and TAB3. The Embo Journal. 30: 4908-20. PMID 22081109 DOI: 10.1038/Emboj.2011.413  0.802
2011 Galluzzi L, Kepp O, Kroemer G. Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy. Oncogene. 31: 2805-8. PMID 21963852 DOI: 10.1038/Onc.2011.459  0.573
2011 Boehrer S, Galluzzi L, Lainey E, Bouteloup C, Tailler M, Harper F, Pierron G, Adès L, Thépot S, Sébert M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 3168-75. PMID 21897118 DOI: 10.4161/Cc.10.18.16599  0.811
2011 Galluzzi L, Kepp O, Kroemer G. FADD: an endogenous inhibitor of RIP3-driven regulated necrosis. Cell Research. 21: 1383-5. PMID 21894190 DOI: 10.1038/Cr.2011.147  0.487
2011 Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 31: 1869-83. PMID 21892204 DOI: 10.1038/Onc.2011.384  0.722
2011 Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (New York, N.Y.). 333: 1109-12. PMID 21868666 DOI: 10.1126/Science.1201940  0.5
2011 Galluzzi L, Kepp O, Kroemer G. Autophagy and innate immunity ally against bacterial invasion. The Embo Journal. 30: 3213-4. PMID 21785408 DOI: 10.1038/Emboj.2011.244  0.438
2011 Morselli E, Shen S, Ruckenstuhl C, Bauer MA, Mariño G, Galluzzi L, Criollo A, Michaud M, Maiuri MC, Chano T, Madeo F, Kroemer G. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200. Cell Cycle (Georgetown, Tex.). 10: 2763-9. PMID 21775823 DOI: 10.4161/Cc.10.16.16868  0.689
2011 Castedo M, Galluzzi L, Vitale I, Senovilla L, Métivier D, Jèmaà M, Rello-Varona S, Kroemer G. Cytofluorometric purification of diploid and tetraploid cancer cells. Methods in Molecular Biology (Clifton, N.J.). 761: 47-63. PMID 21755440 DOI: 10.1007/978-1-61779-182-6_3  0.749
2011 Galluzzi L, Kepp O, Kroemer G. Mitochondrial dynamics: a strategy for avoiding autophagy. Current Biology : Cb. 21: R478-80. PMID 21683905 DOI: 10.1016/J.Cub.2011.05.002  0.531
2011 Büttner S, Ruli D, Vögtle FN, Galluzzi L, Moitzi B, Eisenberg T, Kepp O, Habernig L, Carmona-Gutierrez D, Rockenfeller P, Laun P, Breitenbach M, Khoury C, Fröhlich KU, Rechberger G, et al. A yeast BH3-only protein mediates the mitochondrial pathway of apoptosis Embo Journal. 30: 2779-2792. PMID 21673659 DOI: 10.1038/Emboj.2011.197  0.511
2011 Galluzzi L, Kepp O, Kroemer G. Viperin turns coat in cytomegalovirus infection. Developmental Cell. 20: 737-8. PMID 21664572 DOI: 10.1016/J.Devcel.2011.05.016  0.406
2011 Thépot S, Lainey E, Cluzeau T, Sébert M, Leroy C, Adès L, Tailler M, Galluzzi L, Baran-Marszak F, Roudot H, Eclache V, Gardin C, de Botton S, Auberger P, Fenaux P, et al. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 2323-30. PMID 21654193 DOI: 10.4161/Cc.10.14.16399  0.818
2011 Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nature Reviews. Molecular Cell Biology. 12: 385-92. PMID 21527953 DOI: 10.1038/Nrm3115  0.487
2011 Mariño G, Morselli E, Bennetzen MV, Eisenberg T, Megalou E, Schroeder S, Cabrera S, Bénit P, Rustin P, Criollo A, Kepp O, Galluzzi L, Shen S, Malik SA, Maiuri MC, et al. Longevity-relevant regulation of autophagy at the level of the acetylproteome. Autophagy. 7: 647-9. PMID 21460620 DOI: 10.4161/Auto.7.6.15191  0.811
2011 Rello-Varona S, Kepp O, Vitale I, Michaud M, Senovilla L, Jemaà M, Joza N, Galluzzi L, Castedo M, Kroemer G. An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe. Cell Death & Disease. 1: e25. PMID 21364633 DOI: 10.1038/Cddis.2010.6  0.472
2011 Zischka H, Lichtmannegger J, Schmitt S, Jägemann N, Schulz S, Wartini D, Jennen L, Rust C, Larochette N, Galluzzi L, Chajes V, Bandow N, Gilles VS, DiSpirito AA, Esposito I, et al. Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. The Journal of Clinical Investigation. 121: 1508-18. PMID 21364284 DOI: 10.1172/Jci45401  0.404
2011 Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G. Cell death assays for drug discovery. Nature Reviews. Drug Discovery. 10: 221-37. PMID 21358741 DOI: 10.1038/Nrd3373  0.525
2011 Morselli E, Mariño G, Bennetzen MV, Eisenberg T, Megalou E, Schroeder S, Cabrera S, Bénit P, Rustin P, Criollo A, Kepp O, Galluzzi L, Shen S, Malik SA, Maiuri MC, et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. The Journal of Cell Biology. 192: 615-29. PMID 21339330 DOI: 10.1083/Jcb.201008167  0.822
2011 Kepp O, Galluzzi L, Kroemer G. Mitochondrial control of the NLRP3 inflammasome. Nature Immunology. 12: 199-200. PMID 21321591 DOI: 10.1038/Ni0311-199  0.448
2011 Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, Sukkurwala AQ, Menger L, Zitvogel L, Kroemer G. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Reviews. 30: 61-9. PMID 21249425 DOI: 10.1007/S10555-011-9273-4  0.835
2011 Galluzzi L, Kepp O, Kroemer G. TP53 and MTOR crosstalk to regulate cellular senescence. Aging. 2: 535-7. PMID 20876940 DOI: 10.18632/AGING.100202  0.436
2011 Galluzzi L, Morselli E, Kepp O, Vitale I, Pinti M, Kroemer G. Mitochondrial liaisons of p53. Antioxidants & Redox Signaling. 15: 1691-714. PMID 20712408 DOI: 10.1089/Ars.2010.3504  0.732
2011 Morselli E, Galluzzi L, Kepp O, Mariño G, Michaud M, Vitale I, Maiuri MC, Kroemer G. Oncosuppressive functions of autophagy. Antioxidants & Redox Signaling. 14: 2251-69. PMID 20712403 DOI: 10.1089/Ars.2010.3478  0.737
2011 Galluzzi L, Kepp O, Kroemer G. A new role for cytoplasmic p53: binding and destroying double-stranded RNA. Cell Cycle (Georgetown, Tex.). 9: 2491-2. PMID 20647755 DOI: 10.4161/Cc.9.13.12191  0.497
2010 Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, Criollo A, Galluzzi L, Malik SA, Vitale I, Michaud M, Madeo F, Tavernarakis N, Kroemer G. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death & Disease. 1: e10. PMID 21364612 DOI: 10.1038/Cddis.2009.8  0.829
2010 Vitale I, Galluzzi L, Senovilla L, Criollo A, Jemaà M, Castedo M, Kroemer G. Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death and Differentiation. 18: 1403-13. PMID 21072053 DOI: 10.1038/Cdd.2010.145  0.751
2010 Martins I, Kepp O, Galluzzi L, Senovilla L, Schlemmer F, Adjemian S, Menger L, Michaud M, Zitvogel L, Kroemer G. Surface-exposed calreticulin in the interaction between dying cells and phagocytes. Annals of the New York Academy of Sciences. 1209: 77-82. PMID 20958319 DOI: 10.1111/J.1749-6632.2010.05740.X  0.821
2010 Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Reviews. Molecular Cell Biology. 11: 700-14. PMID 20823910 DOI: 10.1038/Nrm2970  0.494
2010 Vitale I, Jemaà M, Senovilla L, Galluzzi L, Rello-Varona S, Metivier D, Ripoche H, Lazar V, Dessen P, Castedo M, Kroemer G. Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cells. Cell Cycle (Georgetown, Tex.). 9: 2823-9. PMID 20686359  0.712
2010 Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nature Reviews. Drug Discovery. 9: 447-64. PMID 20467424 DOI: 10.1038/Nrd3137  0.51
2010 Galluzzi L, Kepp O, Morselli E, Vitale I, Senovilla L, Pinti M, Zitvogel L, Kroemer G. Viral strategies for the evasion of immunogenic cell death. Journal of Internal Medicine. 267: 526-42. PMID 20433579 DOI: 10.1111/J.1365-2796.2010.02223.X  0.731
2010 Kepp O, Galluzzi L, Zitvogel L, Kroemer G. Pyroptosis - a cell death modality of its kind? European Journal of Immunology. 40: 627-30. PMID 20201017 DOI: 10.1002/Eji.200940160  0.519
2010 Vitale I, Senovilla L, Jemaà M, Michaud M, Galluzzi L, Kepp O, Nanty L, Criollo A, Rello-Varona S, Manic G, Métivier D, Vivet S, Tajeddine N, Joza N, Valent A, et al. Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. The Embo Journal. 29: 1272-84. PMID 20186124 DOI: 10.1038/Emboj.2010.11  0.733
2010 Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Research. 70: 1793-803. PMID 20145152 DOI: 10.1158/0008-5472.Can-09-3112  0.661
2010 Galluzzi L, Kepp O, Zitvogel L, Kroemer G. Bacterial invasion: linking autophagy and innate immunity. Current Biology : Cb. 20: R106-8. PMID 20144769 DOI: 10.1016/J.Cub.2009.12.016  0.413
2010 Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, et al. IKK connects autophagy to major stress pathways. Autophagy. 6: 189-91. PMID 20110771 DOI: 10.4161/Auto.6.1.10818  0.802
2010 Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G. Autophagy regulation by p53. Current Opinion in Cell Biology. 22: 181-5. PMID 20044243 DOI: 10.1016/J.Ceb.2009.12.001  0.823
2010 Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, Criollo A, Galluzzi L, Malik SA, Vitale I, Michaud M, Madeo F, Tavernarakis N, Kroemer G. The life span-prolonging effect of sirtuin-1 is mediated by autophagy. Autophagy. 6: 186-8. PMID 20023410 DOI: 10.4161/Auto.6.1.10817  0.829
2010 Galluzzi L, Morselli E, Kepp O, Maiuri MC, Kroemer G. Defective autophagy control by the p53 rheostat in cancer. Cell Cycle (Georgetown, Tex.). 9: 250-5. PMID 20023384 DOI: 10.4161/Cc.9.2.10493  0.745
2010 Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, et al. The IKK complex contributes to the induction of autophagy. The Embo Journal. 29: 619-31. PMID 19959994 DOI: 10.1038/Emboj.2009.364  0.811
2010 Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G. Mitochondrial gateways to cancer. Molecular Aspects of Medicine. 31: 1-20. PMID 19698742 DOI: 10.1016/J.Mam.2009.08.002  0.812
2010 Vitale I, Jemaá M, Senovilla L, Galluzzi L, Rello-Varona S, Métivier D, Ripoche H, Lazar V, Dessen P, Castedo M, Kroemer G. Involvement of p38α in the mitotic progression ofp53-/-tetraploid cells Cell Cycle. 9: 2895-2901. DOI: 10.4161/Cc.9.14.12254  0.732
2009 Morselli E, Galluzzi L, Kepp O, Criollo A, Maiuri MC, Tavernarakis N, Madeo F, Kroemer G. Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol. Aging. 1: 961-70. PMID 20157579  0.712
2009 Kepp O, Galluzzi L, Giordanetto F, Tesniere A, Vitale I, Martins I, Schlemmer F, Adjemian S, Zitvogel L, Kroemer G. Disruption of the PP1/GADD34 complex induces calreticulin exposure. Cell Cycle (Georgetown, Tex.). 8: 3971-7. PMID 19901557 DOI: 10.4161/Cc.8.23.10191  0.8
2009 Galluzzi L, Giordanetto F, Kroemer G. Targeting HSP70 for cancer therapy. Molecular Cell. 36: 176-7. PMID 19854128 DOI: 10.1016/J.Molcel.2009.10.003  0.462
2009 Zhivotovsky B, Galluzzi L, Kepp O, Kroemer G. Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery. Cell Death and Differentiation. 16: 1419-25. PMID 19696789 DOI: 10.1038/Cdd.2009.118  0.486
2009 Galluzzi L, Kepp O, Kroemer G. RIP kinases initiate programmed necrosis. Journal of Molecular Cell Biology. 1: 8-10. PMID 19679643 DOI: 10.1093/Jmcb/Mjp007  0.498
2009 Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nature Reviews. Neuroscience. 10: 481-94. PMID 19543220 DOI: 10.1038/Nrn2665  0.482
2009 Morselli E, Galluzzi L, Kepp O, Kroemer G. Nutlin kills cancer cells via mitochondrial p53. Cell Cycle (Georgetown, Tex.). 8: 1647-8. PMID 19448434 DOI: 10.4161/Cc.8.11.8746  0.706
2009 Boehrer S, Adès L, Tajeddine N, Hofmann WK, Kriener S, Bug G, Ottmann OG, Ruthardt M, Galluzzi L, Fouassier C, Tailler M, Olaussen KA, Gardin C, Eclache V, de Botton S, et al. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene. 28: 2205-18. PMID 19398952 DOI: 10.1038/Onc.2009.69  0.764
2009 Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death and Differentiation. 16: 1093-107. PMID 19373242 DOI: 10.1038/Cdd.2009.44  0.73
2009 Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, Kroemer G. Anti- and pro-tumor functions of autophagy. Biochimica Et Biophysica Acta. 1793: 1524-32. PMID 19371598 DOI: 10.1016/J.Bbamcr.2009.01.006  0.729
2009 Senovilla L, Vitale I, Galluzzi L, Vivet S, Joza N, Younes AB, Rello-Varona S, Castedo M, Kroemer G. p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis. Cell Cycle (Georgetown, Tex.). 8: 1380-5. PMID 19342895 DOI: 10.4161/Cc.8.9.8305  0.551
2009 Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L, Joza N, Vitale I, Morselli E, Tailler M, Castedo M, Maiuri MC, Molgó J, Szabadkai G, Lavandero S, et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death and Differentiation. 16: 1006-17. PMID 19325567 DOI: 10.1038/Cdd.2009.34  0.732
2009 Kepp O, Senovilla L, Galluzzi L, Panaretakis T, Tesniere A, Schlemmer F, Madeo F, Zitvogel L, Kroemer G. Viral subversion of immunogenic cell death. Cell Cycle (Georgetown, Tex.). 8: 860-9. PMID 19221507 DOI: 10.4161/Cc.8.6.7939  0.825
2009 Galluzzi L, Kroemer G. Shigella targets the mitochondrial checkpoint of programmed necrosis. Cell Host & Microbe. 5: 107-9. PMID 19218080 DOI: 10.1016/J.Chom.2009.01.002  0.498
2009 Mondragón L, Galluzzi L, Mouhamad S, Orzáez M, Vicencio JM, Vitale I, Moure A, Messeguer A, Perez-Paya E, Kroemer G. A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint. Apoptosis : An International Journal On Programmed Cell Death. 14: 182-90. PMID 19152031 DOI: 10.1007/S10495-008-0310-X  0.475
2009 Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell. 135: 1161-3. PMID 19109884 DOI: 10.1016/J.Cell.2008.12.004  0.418
2009 Galluzzi L, Morselli E, Kepp O, Kroemer G. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochimica Et Biophysica Acta. 1787: 402-13. PMID 18848916 DOI: 10.1016/J.Bbabio.2008.09.006  0.694
2009 Galluzzi L, Vitale I, Kepp O, Séror C, Hangen E, Perfettini JL, Modjtahedi N, Kroemer G. Methods to dissect mitochondrial membrane permeabilization in the course of apoptosis. Methods in Enzymology. 442: 355-74. PMID 18662579 DOI: 10.1016/S0076-6879(08)01418-3  0.504
2009 Boehrer S, Galluzzi L, Ades L, Fouassier C, Gardin C, Fenaux P, Kroemer G. Increased Proliferation Induced by Constitutive Activation of the Src-Kinase Lyn and Aberrant mTOR Signaling in AML Is Abrogated by the EGFR-Inhibitor Erlotinib. Blood. 114: 3813-3813. DOI: 10.1182/Blood.V114.22.3813.3813  0.511
2008 Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, Vicencio JM, Soussi T, Kroemer G. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle (Georgetown, Tex.). 7: 3056-61. PMID 18818522 DOI: 10.4161/Cc.7.19.6751  0.806
2008 Galluzzi L, Morselli E, Vicencio JM, Kepp O, Joza N, Tajeddine N, Kroemer G. Life, death and burial: multifaceted impact of autophagy. Biochemical Society Transactions. 36: 786-90. PMID 18793137 DOI: 10.1042/Bst0360786  0.741
2008 Vitale I, Senovilla L, Galluzzi L, Criollo A, Vivet S, Castedo M, Kroemer G. Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells. Cell Cycle (Georgetown, Tex.). 7: 1956-61. PMID 18642443 DOI: 10.4161/Cc.7.13.6073  0.488
2008 Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G. Targeting p53 to mitochondria for cancer therapy. Cell Cycle (Georgetown, Tex.). 7: 1949-55. PMID 18642442 DOI: 10.4161/Cc.7.13.6222  0.743
2008 Boehrer S, Adès L, Galluzzi L, Tajeddine N, Tailler M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison. Biochemical Pharmacology. 76: 1417-25. PMID 18617157 DOI: 10.1016/J.Bcp.2008.05.024  0.766
2008 Morselli E, Galluzzi L, Kroemer G. Mechanisms of p53-mediated mitochondrial membrane permeabilization. Cell Research. 18: 708-10. PMID 18596700 DOI: 10.1038/Cr.2008.77  0.67
2008 Hoffmann J, Vitale I, Buchmann B, Galluzzi L, Schwede W, Senovilla L, Skuballa W, Vivet S, Lichtner RB, Vicencio JM, Panaretakis T, Siemeister G, Lage H, Nanty L, Hammer S, et al. Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. Cancer Research. 68: 5301-8. PMID 18593931 DOI: 10.1158/0008-5472.Can-08-0237  0.598
2008 Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. Plos Pathogens. 4: e1000018. PMID 18516228 DOI: 10.1371/Journal.Ppat.1000018  0.716
2008 Galluzzi L, Kepp O, Tajeddine N, Kroemer G. Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene. 27: 4633-5. PMID 18469866 DOI: 10.1038/Onc.2008.114  0.539
2008 Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, Criollo A, Morselli E, Zhu C, Harper F, Nannmark U, Samara C, Pinton P, Vicencio JM, Carnuccio R, et al. Regulation of autophagy by cytoplasmic p53. Nature Cell Biology. 10: 676-87. PMID 18454141 DOI: 10.1038/Ncb1730  0.825
2008 Vicencio JM, Galluzzi L, Tajeddine N, Ortiz C, Criollo A, Tasdemir E, Morselli E, Ben Younes A, Maiuri MC, Lavandero S, Kroemer G. Senescence, apoptosis or autophagy? When a damaged cell must decide its path--a mini-review. Gerontology. 54: 92-9. PMID 18451641 DOI: 10.1159/000129697  0.833
2008 Tasdemir E, Galluzzi L, Maiuri MC, Criollo A, Vitale I, Hangen E, Modjtahedi N, Kroemer G. Methods for assessing autophagy and autophagic cell death. Methods in Molecular Biology (Clifton, N.J.). 445: 29-76. PMID 18425442 DOI: 10.1007/978-1-59745-157-4_3  0.795
2008 Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, Araujo N, Pinna G, Larochette N, Zamzami N, Modjtahedi N, Harel-Bellan A, Kroemer G. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene. 27: 4221-32. PMID 18362892 DOI: 10.1038/Onc.2008.63  0.817
2008 Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. To die or not to die: that is the autophagic question. Current Molecular Medicine. 8: 78-91. PMID 18336289 DOI: 10.2174/156652408783769616  0.805
2008 Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, Abrams JM, Tavernarakis N, Penninger J, Madeo F, Kroemer G. No death without life: vital functions of apoptotic effectors. Cell Death and Differentiation. 15: 1113-23. PMID 18309324 DOI: 10.1038/Cdd.2008.28  0.788
2008 Pauleau AL, Galluzzi L, Scholz SR, Larochette N, Kepp O, Kroemer G. Unexpected role of the phosphate carrier in mitochondrial fragmentation. Cell Death and Differentiation. 15: 616-8. PMID 18174900 DOI: 10.1038/Sj.Cdd.4402295  0.384
2008 Boehrer S, Adès L, Braun T, Galluzzi L, Grosjean J, Fabre C, Le Roux G, Gardin C, Martin A, de Botton S, Fenaux P, Kroemer G. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood. 111: 2170-80. PMID 17925489 DOI: 10.1182/Blood-2007-07-100362  0.813
2008 Boehrer S, Ades L, Tajeddine N, Galluzzi L, Hofmann W, Fenaux P, Kroemer G. Selective Suppression of the DNA Damage Response in Acute Myeloid Leukemia Versus Myelodysplastic Syndrome. Blood. 112: 1656-1656. DOI: 10.1182/Blood.V112.11.1656.1656  0.465
2007 Vitale I, Galluzzi L, Vivet S, Nanty L, Dessen P, Senovilla L, Olaussen KA, Lazar V, Prudhomme M, Golsteyn RM, Castedo M, Kroemer G. Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway. Plos One. 2: e1337. PMID 18159231 DOI: 10.1371/Journal.Pone.0001337  0.592
2007 Mouhamad S, Galluzzi L, Zermati Y, Castedo M, Kroemer G. Apaf-1 Deficiency Causes Chromosomal Instability. Cell Cycle (Georgetown, Tex.). 6: 3103-3107. PMID 18073531 DOI: 10.4161/Cc.6.24.5046  0.523
2007 Zermati Y, Mouhamad S, Stergiou L, Besse B, Galluzzi L, Boehrer S, Pauleau AL, Rosselli F, D'Amelio M, Amendola R, Castedo M, Hengartner M, Soria JC, Cecconi F, Kroemer G. Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Molecular Cell. 28: 624-37. PMID 18042457 DOI: 10.1016/J.Molcel.2012.10.006  0.818
2007 de La Motte Rouge T, Galluzzi L, Olaussen KA, Zermati Y, Tasdemir E, Robert T, Ripoche H, Lazar V, Dessen P, Harper F, Pierron G, Pinna G, Araujo N, Harel-Belan A, Armand JP, et al. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Research. 67: 6253-62. PMID 17616683 DOI: 10.1158/0008-5472.Can-07-0538  0.779
2007 Galluzzi L, Kroemer G. Mitochondrial apoptosis without VDAC. Nature Cell Biology. 9: 487-9. PMID 17473857 DOI: 10.1038/Ncb0507-487  0.47
2007 Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G. Cell death modalities: classification and pathophysiological implications. Cell Death and Differentiation. 14: 1237-43. PMID 17431418 DOI: 10.1038/Sj.Cdd.4402148  0.503
2007 Galluzzi L, Zamzami N, de La Motte Rouge T, Lemaire C, Brenner C, Kroemer G. Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 12: 803-13. PMID 17294081 DOI: 10.1007/S10495-007-0720-1  0.683
2007 Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiological Reviews. 87: 99-163. PMID 17237344 DOI: 10.1152/Physrev.00013.2006  0.512
2007 Criollo A, Galluzzi L, Maiuri MC, Tasdemir E, Lavandero S, Kroemer G. Mitochondrial control of cell death induced by hyperosmotic stress. Apoptosis : An International Journal On Programmed Cell Death. 12: 3-18. PMID 17080328 DOI: 10.1007/S10495-006-0328-X  0.801
2007 Galluzzi L, Karp M. Intracellular redox equilibrium and growth phase affect the performance of luciferase-based biosensors. Journal of Biotechnology. 127: 188-98. PMID 16891024 DOI: 10.1016/J.Jbiotec.2006.06.019  0.344
2007 Boehrer S, Ades L, Braun T, Galluzzi L, Grosjean J, Fabre C, Le Roux G, Gardin C, Martin A, de Botton S, Fenaux P, Kroemer G. The EGFR-Inhibitor Erlotinib Induces Differentiation, Cell Cycle Arrest and Apoptosis in EGFR-Negative Cells of MDS and AML. Blood. 110: 399-399. DOI: 10.1182/Blood.V110.11.399.399  0.821
2007 Boehrer S, Ades L, Galluzzi L, Olaussen K, Braun T, Grosjean J, Fabre C, de Botton S, Fenaux P, Kroemer G. Further Evidence That MDS and AML Cells Exhibit a Differential Capacity To Activate the DNA-Damage Response (DDR) Pathways. Blood. 110: 2438-2438. DOI: 10.1182/Blood.V110.11.2438.2438  0.815
2007 Boehrer S, Adàs L, Braun T, Galluzzi L, Grosjean J, Fabre C, de Botton S, Gardin C, Fenaux P, Kroemer G. P039 The EGFR-inhibitor erlotinib exhibits various off-target effects in MDS and AML Leukemia Research. 31: S62. DOI: 10.1016/S0145-2126(07)70109-1  0.755
2006 Galluzzi L, Larochette N, Zamzami N, Kroemer G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene. 25: 4812-30. PMID 16892093 DOI: 10.1038/Sj.Onc.1209598  0.72
2006 Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death and Differentiation. 13: 1423-33. PMID 16676004 DOI: 10.1038/Sj.Cdd.4401950  0.464
2006 De La Motte Rouge T, Zermati Y, Galluzzi L, Armand J, Wong T, Kroemer G, Soria J. 618 POSTER A novel tyrosine kinase inhibitor exhibits significant anti-proliferative/pro-apoptotic effects in non-small cell lung cancer models European Journal of Cancer Supplements. 4: 186-187. DOI: 10.1016/S1359-6349(06)70623-1  0.472
2003 Galluzzi L, Virtanen P, Karp M. A real-time analysis of QacR-regulated multidrug resistance in Staphylococcus aureus. Biochemical and Biophysical Research Communications. 301: 24-30. PMID 12535635 DOI: 10.1016/S0006-291X(02)02992-3  0.316
Show low-probability matches.